Masashi Mizokami
#122,932
Most Influential Person Now
Masashi Mizokami's AcademicInfluence.com Rankings
Masashi Mizokamibiology Degrees
Biology
#7565
World Rank
#10507
Historical Rank
Virology
#159
World Rank
#164
Historical Rank
Genetics
#729
World Rank
#821
Historical Rank
Molecular Biology
#881
World Rank
#904
Historical Rank
Download Badge
Biology
Masashi Mizokami's Degrees
- PhD Molecular Biology University of Tokyo
- Masters Biochemistry Kyoto University
- Bachelors Biology Kyoto University
Similar Degrees You Can Earn
Why Is Masashi Mizokami Influential?
(Suggest an Edit or Addition)Masashi Mizokami's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Production of infectious hepatitis C virus in tissue culture from a cloned viral genome (2005) (2882)
- Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C (2009) (1815)
- Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes (2005) (1570)
- A proposed system for the nomenclature of hepatitis C viral genotypes (1994) (1100)
- Significance of serum hepatitis C virus RNA levels in chronic hepatitis C (1993) (840)
- Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon. (2003) (634)
- Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization (1998) (538)
- Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B. (2009) (514)
- New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a (1997) (491)
- Antiviral drug‐resistant HBV: Standardization of nomenclature and assays and recommendations for management (2007) (474)
- Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C. (2010) (438)
- A Genetic Variant of Hepatitis B Virus Divergent from Known Human and Ape Genotypes Isolated from a Japanese Patient and Provisionally Assigned to New Genotype J (2009) (429)
- Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan (2001) (424)
- A case‐control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C (2001) (395)
- Hepatitis C Virus Infection in Patients with B-Cell Non-Hodgkin Lymphoma (1997) (393)
- Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial. (2015) (344)
- A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades (2002) (336)
- Hepatitis B Virus of Genotype B with or without Recombination with Genotype C over the Precore Region plus the Core Gene (2002) (297)
- Classifying Hepatitis B Virus Genotypes (2003) (295)
- Influence of hepatitis B virus genotypes on the intra‐ and extracellular expression of viral DNA and antigens (2006) (272)
- A serum “sweet-doughnut” protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis (2013) (271)
- Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis—A comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma (2000) (269)
- Hepatitis B virus genotype assignment using restriction fragment length polymorphism patterns (1999) (258)
- Ledipasvir and sofosbuvir in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis: An integrated safety and efficacy analysis (2015) (256)
- Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population. (2012) (244)
- Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection (2006) (221)
- Host-independent evolution and a genetic classification of the hepadnavirus family based on nucleotide sequences. (1989) (221)
- A novel variant genotype C of hepatitis B virus identified in isolates from Australian Aborigines: complete genome sequence and phylogenetic relatedness. (2001) (217)
- Application of six hepatitis C virus genotyping systems to sera from chronic hepatitis C patients in the United States. (1995) (214)
- Epidemiologic and virologic characteristics of hepatitis B virus genotype B having the recombination with genotype C. (2003) (214)
- Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP) (2014) (214)
- Geographical and genetic diversity of the human hepatitis B virus (2010) (213)
- Distribution of Hepatitis C Virus Genotypes Determined by Line Probe Assay in Patients with Chronic Hepatitis C Seen at Tertiary Referral Centers in the United States (1996) (207)
- NS5A resistance-associated substitutions in patients with genotype 1 hepatitis C virus: Prevalence and effect on treatment outcome. (2017) (204)
- Sofosbuvir plus ribavirin in Japanese patients with chronic genotype 2 HCV infection: an open‐label, phase 3 trial (2014) (195)
- A new subtype (subgenotype) Ac (A3) of hepatitis B virus and recombination between genotypes A and E in Cameroon. (2005) (188)
- Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients (2014) (186)
- Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels (2007) (180)
- Hepatitis B Virus Genotype Distribution among Chronic Hepatitis B Virus Carriers in Shanghai, China (2001) (178)
- Genomic and molecular evolutionary analysis of a newly identified infectious agent (SEN virus) and its relationship to the TT virus family. (2001) (169)
- A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C. Japan HBV Genotype Research Group. (2001) (168)
- Consumption of n-3 fatty acids and fish reduces risk of hepatocellular carcinoma. (2012) (164)
- A case‐control study for differences among hepatitis B virus infections of genotypes A (subtypes Aa and Ae) and D (2004) (161)
- Reactivation of hepatitis B virus following systemic chemotherapy for malignant lymphoma (2009) (158)
- Epidemiological and sequence differences between two subtypes (Ae and Aa) of hepatitis B virus genotype A. (2004) (155)
- A novel serum marker, glycosylated Wisteria floribunda agglutinin-positive Mac-2 binding protein (WFA+-M2BP), for assessing liver fibrosis (2014) (149)
- Hepatitis B Virus Core-Related Antigens as Markers for Monitoring Chronic Hepatitis B Infection (2007) (145)
- Molecular Evolution of Hepatitis B Virus over 25 Years (2006) (145)
- Donor Complications Associated With Living Donor Liver Transplantation in Japan (2009) (145)
- An updated analysis of hepatitis C virus genotypes and subtypes based on the complete coding region (2012) (142)
- Association between Wisteria floribunda agglutinin-positive Mac-2 binding protein and the fibrosis stage of non-alcoholic fatty liver disease (2015) (141)
- Nonhepatic Cell Lines HeLa and 293 Support Efficient Replication of the Hepatitis C Virus Genotype 2a Subgenomic Replicon (2005) (140)
- Genome-Wide Association Study Confirming Association of HLA-DP with Protection against Chronic Hepatitis B and Viral Clearance in Japanese and Korean (2012) (135)
- Specific mutations in enhancer II/core promoter of hepatitis B virus subgenotypes C1/C2 increase the risk of hepatocellular carcinoma. (2006) (132)
- Dynamics of genome change in the E2/NS1 region of hepatitis C virus in vivo. (1993) (129)
- Characterization of hepatitis D virus genotype III among Yucpa Indians in Venezuela. (2001) (129)
- Characteristics of Hepatitis B Virus Isolates of Genotype G and Their Phylogenetic Differences from the Other Six Genotypes (A through F) (2002) (129)
- Genotype 2a Hepatitis C Virus Subgenomic Replicon Can Replicate in HepG2 and IMY-N9 Cells* (2004) (126)
- Simple fluorescent enzyme immunoassay for detection and quantification of hepatitis C viremia. (1995) (126)
- Novel subtypes (subgenotypes) of hepatitis B virus genotypes B and C among chronic liver disease patients in the Philippines. (2006) (124)
- Distribution of Hepatitis B Virus Genotypes among Patients with Chronic Infection in Japan Shifting toward an Increase of Genotype A (2009) (124)
- Induction of IFN-λ3 as an additional effect of nucleotide, not nucleoside, analogues: a new potential target for HBV infection (2016) (123)
- Pre-treatment prediction of response to pegylated-interferon plus ribavirin for chronic hepatitis C using genetic polymorphism in IL28B and viral factors. (2011) (122)
- New genotypes of TT virus (TTV) and a genotyping assay based on restriction fragment length polymorphism 1 (1998) (122)
- Helicobacter pylori in North and South America before Columbus. (2001) (121)
- Molecular tracing of the global hepatitis C virus epidemic predicts regional patterns of hepatocellular carcinoma mortality. (2006) (121)
- Constrained evolution with respect to gene overlap of hepatitis B virus (2009) (121)
- Hepatitis B e antigen in sera from individuals infected with hepatitis B virus of genotype G (2002) (118)
- A comprehensive system for consistent numbering of HCV sequences, proteins and epitopes (2006) (115)
- Monitoring of Hepatitis B Virus (HBV) DNA and Risk of HBV Reactivation in B-Cell Lymphoma: A Prospective Observational Study. (2015) (114)
- Loss of serum HCV RNA at week 4 of interferon‐α therapy is associated with more favorable long‐term response in patients with chronic hepatitis C (1995) (114)
- Genotypes and phylogenetic characterization of hepatitis B and delta viruses in Egypt (2003) (113)
- Influence of hepatitis B virus genotypes on the development of preS deletions and advanced liver disease (2003) (112)
- Effect of Coffee and Green Tea Consumption on the Risk of Liver Cancer: Cohort Analysis by Hepatitis Virus Infection Status (2009) (111)
- Hepatitis B Virus Genotypes and Hepatocellular Carcinoma in Japan (2003) (110)
- Phylogenetic relatedness and genetic diversity of hepatitis B virus isolates in Eastern India (2006) (109)
- Role of hepatitis B virus genotypes Ba and C, core promoter and precore mutations on hepatocellular carcinoma: a case control study. (2004) (109)
- Mac-2 binding protein glycan isomer (M2BPGi) is a new serum biomarker for assessing liver fibrosis: more than a biomarker of liver fibrosis (2018) (106)
- SARS-CoV-2 infections and COVID-19 mortalities strongly correlate with ACE1 I/D genotype (2020) (105)
- Clinical implications of viral quasispecies heterogeneity in chronic hepatitis C (1996) (101)
- Hepatitis B Virus Genotype C Prevails Among Chronic Carriers of the Virus in Korea (2005) (100)
- Antigenicities of Group I and II hepatitis C virus polypeptides--molecular basis of diagnosis. (1993) (97)
- Reactivation of hepatitis B virus following rituximab-plus-steroid combination chemotherapy (2010) (94)
- Evolutionary relationship of hepatitis C, pesti‐, flavi‐, plantviruses, and newly discovered GB hepatitis agents (1996) (93)
- Human blood dendritic cell antigen 3 (BDCA3)+ dendritic cells are a potent producer of interferon‐λ in response to hepatitis C virus (2013) (93)
- Detection of Anti-Hepatitis C Virus Effects of Interferon and Ribavirin by a Sensitive Replicon System (2005) (92)
- Impairment of Hepatitis B Virus Virion Secretion by Single-Amino-Acid Substitutions in the Small Envelope Protein and Rescue by a Novel Glycosylation Site (2010) (92)
- Exponential Spread of Hepatitis C Virus Genotype 4a in Egypt (2004) (92)
- A pilot randomized, controlled trial of the effect of iron depletion on long-term response to α-interferon in patients with chronic hepatitis C (1998) (91)
- Cyclosporin derivatives inhibit hepatitis B virus entry without interfering with NTCP transporter activity (2016) (91)
- Helicobacter pylori in North and South America before Columbus (2002) (89)
- β‐Catenin Accumulation and Mutation of Exon 3 of the β‐Catenin Gene in Hepatocellular Carcinoma (1999) (89)
- Determination of hepatitis B virus genotype G by polymerase chain reaction with hemi-nested primers. (2001) (86)
- Risk factors for long‐term persistence of serum hepatitis B surface antigen following acute hepatitis B virus infection in Japanese adults (2014) (84)
- Two subtypes of genotype B (Ba and Bj) of hepatitis B virus in Japan. (2004) (84)
- Soluble MICA and a MICA Variation as Possible Prognostic Biomarkers for HBV-Induced Hepatocellular Carcinoma (2012) (83)
- Difference of Hepatitis B Virus Genotype Distribution in Two Groups of Mexican Patients with Different Risk Factors (2006) (82)
- Genome-wide association study identified ITPA/DDRGK1 variants reflecting thrombocytopenia in pegylated interferon and ribavirin therapy for chronic hepatitis C. (2011) (82)
- Transmissibility of hepatitis B virus (HBV) infection through blood transfusion from blood donors with occult HBV infection. (2011) (81)
- The Duration of Lamivudine Therapy for Chronic Hepatitis B: Cessation vs. Continuation of Treatment After HBeAg Seroconversion (2009) (81)
- Classification of hepatitis B virus genotype B into 2 major types based on characterization of a novel subgenotype in Arctic indigenous populations. (2007) (81)
- Hepatitis C virus (HCV) subtype prevalence in Chiang Mai, Thailand, and identification of novel subtypes of HCV major type 6 (1996) (81)
- Recurrence and mortality among patients hospitalized for acute lower gastrointestinal bleeding. (2015) (79)
- Hepatitis B virus (HBV) genotypes/subgenotypes in China: mutations in core promoter and precore/core and their clinical implications. (2007) (78)
- Development and Validation of a Risk Scoring System for Severe Acute Lower Gastrointestinal Bleeding. (2016) (78)
- Hepatitis B and C Viruses Infection, Lifestyle and Genetic Polymorphisms as Risk Factors for Hepatocellular Carcinoma in Haimen, China (2002) (77)
- Increase in colonic diverticulosis and diverticular hemorrhage in an aging society: lessons from a 9-year colonoscopic study of 28,192 patients in Japan (2014) (77)
- Long noncoding RNA #32 contributes to antiviral responses by controlling interferon-stimulated gene expression (2016) (76)
- Clinical and Virological Characteristics of Hepatitis B Virus Subgenotypes Ba, C1, and C2 in China (2007) (76)
- The rs8099917 Polymorphism, When Determined by a Suitable Genotyping Method, Is a Better Predictor for Response to Pegylated Alpha Interferon/Ribavirin Therapy in Japanese Patients than Other Single Nucleotide Polymorphisms Associated with Interleukin-28B (2011) (76)
- When Should “I” Consider a New Hepatitis B Virus Genotype? (2008) (76)
- Distribution of hepatitis B virus (HBV) genotypes among HBV carriers in the cote d'Ivoire: Complete genome sequence and phylogenetic relatedness of HBV genotype E (2003) (75)
- Genotype B and younger patient age associated with better response to low-dose therapy: a trial with pegylated/nonpegylated interferon-alpha-2b for hepatitis B e antigen-positive patients with chronic hepatitis B in China. (2007) (74)
- ITPA gene variant protects against anemia induced by pegylated interferon‐α and ribavirin therapy for Japanese patients with chronic hepatitis C (2010) (73)
- Serum YKL-40 as a marker of liver fibrosis in patients with non-alcoholic fatty liver disease (2016) (72)
- Alcohol and Smoking Affect Risk of Uncomplicated Colonic Diverticulosis in Japan (2013) (71)
- Eight genotypes (A–H) of hepatitis B virus infecting patients from San Francisco and their demographic, clinical, and virological characteristics (2004) (71)
- Hepatitis B virus genotypes and clinical manifestation among hepatitis B carriers in Thailand (2002) (70)
- Clinical outcome and virologic profiles of severe hepatitis B exacerbation due to YMDD mutations. (2003) (70)
- Epidemiological study of hepatitis B virus genotypes, core promoter and precore mutations of chronic hepatitis B infection in Hong Kong. (2004) (70)
- Spatial and chronological differences in hepatitis B virus genotypes from patients with acute hepatitis B in Japan. (2006) (69)
- Characterization of hepatitis B virus genotypes among Yucpa Indians in Venezuela. (2001) (69)
- The cyclic GMP‐AMP synthetase–STING signaling pathway is required for both the innate immune response against HBV and the suppression of HBV assembly (2016) (69)
- GB virus C/hepatitis G virus infection in southern China. (1997) (68)
- Comparison of genotypes C and D of the hepatitis B virus in Japan: A clinical and molecular biological study (2004) (68)
- Least Microtransfusion From Mother to Fetus in Elective Cesarean Delivery (1996) (67)
- Measurement of hepatitis B virus core-related antigen as predicting factor for relapse after cessation of lamivudine therapy for chronic hepatitis B virus infection. (2006) (67)
- Three different GB virus C/hepatitis G virus genotypes (1997) (67)
- Safety and efficacy of ledipasvir/sofosbuvir for the treatment of genotype 1 hepatitis C in subjects aged 65 years or older (2016) (67)
- Strategy for glycoproteomics: identification of glyco-alteration using multiple glycan profiling tools. (2009) (65)
- Hepatitis C Virus Genotypes 1 and 2 Respond to Interferon-a with Different (1995) (65)
- Two subtypes (subgenotypes) of hepatitis B virus genotype C: A novel subtyping assay based on restriction fragment length polymorphism. (2005) (65)
- A Novel Tricyclic Polyketide, Vanitaracin A, Specifically Inhibits the Entry of Hepatitis B and D Viruses by Targeting Sodium Taurocholate Cotransporting Polypeptide (2015) (65)
- Vegetable, fruit and antioxidant nutrient consumption and subsequent risk of hepatocellular carcinoma: a prospective cohort study in Japan (2009) (64)
- High seropositivity of Japanese homosexual men for amebic infection. (1989) (64)
- Epidemiology of genotypes of hepatitis C virus in Japanese patients with type C chronic liver diseases: A multi‐institution analysis (1995) (64)
- Confirmation of hepatitis C virus transmission through needlestick accidents by molecular evolutionary analysis. (1994) (63)
- The NS3 Helicase and NS5B-to-3′X Regions Are Important for Efficient Hepatitis C Virus Strain JFH-1 Replication in Huh7 Cells (2007) (63)
- Multilectin assay for detecting fibrosis-specific glyco-alteration by means of lectin microarray. (2011) (62)
- Serum Wisteria Floribunda Agglutinin-Positive Mac-2 Binding Protein Values Predict the Development of Hepatocellular Carcinoma among Patients with Chronic Hepatitis C after Sustained Virological Response (2015) (62)
- GB virus C/hepatitis G virus infection among Japanese patients with chronic liver diseases and blood donors. (1996) (61)
- Safety, Tolerability, and Preliminary Efficacy of the Anti-Fibrotic Small Molecule PRI-724, a CBP/β-Catenin Inhibitor, in Patients with Hepatitis C Virus-related Cirrhosis: A Single-Center, Open-Label, Dose Escalation Phase 1 Trial (2017) (60)
- Detection of hepatitis C virus natural recombinant RF1_2k/1b strain among intravenous drug users in Uzbekistan (2008) (59)
- Impact of interleukin-1beta genetic polymorphisms on the development of hepatitis C virus-related hepatocellular carcinoma in Japan. (2003) (59)
- Geographic distribution of hepatitis C virus genotype 6 subtypes in Thailand (2010) (59)
- Serum hepatitis C virus RNA level as a predictor of subsequent response to interferon‐α therapy in Japanese patients with chronic hepatitis C (1994) (58)
- Occult hepatitis B in the genotype H‐infected Nahuas and Huichol native Mexican population (2010) (58)
- Predictors for Identification of Stigmata of Recent Hemorrhage on Colonic Diverticula in Lower Gastrointestinal Bleeding (2015) (58)
- T1653 mutation in the box alpha increases the risk of hepatocellular carcinoma in patients with chronic hepatitis B virus genotype C infection. (2006) (58)
- Direct cytopathic effects of particular hepatitis B virus genotypes in severe combined immunodeficiency transgenic with urokinase-type plasminogen activator mouse with human hepatocytes. (2009) (58)
- Optimization for the detection of hepatitis C virus antigens in the liver. (1994) (57)
- Visceral abdominal fat measured by computed tomography is associated with an increased risk of colorectal adenoma (2014) (57)
- Effects of bowel preparation on the human gut microbiome and metabolome (2019) (57)
- Epidemic spread of hepatitis C virus genotype 3a and relation to high incidence of hepatocellular carcinoma in Pakistan (2009) (57)
- A new class of hepatitis B and D virus entry inhibitors, proanthocyanidin and its analogs, that directly act on the viral large surface proteins (2017) (57)
- Difference in prognosis between patients infected with hepatitis B virus with genotype B and those with genotype C in the Okinawa Islands: A prospective study (2003) (56)
- RNA Polymerase Activity and Specific RNA Structure Are Required for Efficient HCV Replication in Cultured Cells (2010) (56)
- Lower GI bleeding risk of nonsteroidal anti-inflammatory drugs and antiplatelet drug use alone and the effect of combined therapy. (2014) (56)
- Metabolic factors and subsequent risk of hepatocellular carcinoma by hepatitis virus infection status: a large-scale population-based cohort study of Japanese men and women (JPHC Study Cohort II) (2009) (56)
- Colonic diverticular hemorrhage associated with the use of nonsteroidal anti‐inflammatory drugs, low‐dose aspirin, antiplatelet drugs, and dual therapy (2014) (55)
- Wisteria floribunda agglutinin positive human Mac‐2‐binding protein as a predictor of hepatocellular carcinoma development in chronic hepatitis C patients (2015) (55)
- Origin and Evolution of the Unique Hepatitis C Virus Circulating Recombinant Form 2k/1b (2011) (55)
- Clinicopathological characteristics and diagnostic performance of Wisteria floribunda agglutinin positive Mac-2-binding protein as a preoperative serum marker of liver fibrosis in hepatocellular carcinoma (2015) (55)
- Molecular epidemiology and interferon susceptibility of the natural recombinant hepatitis C virus strain RF1_2k/1b. (2008) (55)
- Routes of Transimission of Hepatitis C Virus in an Endemic Rural Area of Japan Molecular Epidemiologic Study of Hepatitis C Virus Infection (1997) (55)
- Intrahepatic expression of hepatitis C virus antigens in chronic liver disease (1995) (54)
- Hepatitis B virus genotypes in Uzbekistan and validity of two different systems for genotyping (2002) (54)
- Development and public release of a comprehensive hepatitis virus database (2008) (54)
- Polymerase chain reaction assay for hepatitis C virus RNA using a single tube for reverse transcription and serial rounds of amplification with nested primer pairs (1992) (54)
- Accuracy of endoscopic diagnosis of Helicobacter pylori infection according to level of endoscopic experience and the effect of training (2013) (54)
- Genotype, serotype, and phylogenetic characterization of the complete genome sequence of hepatitis B virus isolates from Malawian chronic carriers of the virus (2003) (53)
- Frequent coinfection with hepatitis B virus strains of distinct genotypes detected by hybridization with type-specific probes immobilized on a solid-phase support. (2003) (53)
- Reduction of synonymous substitutions in the core protein gene of hepatitis C virus (2004) (52)
- Different hepatitis B virus genotype distributions among asymptomatic carriers and patients with liver diseases in Nanning, southern China. (2002) (52)
- Dysregulation of Retinoic Acid Receptor Diminishes Hepatocyte Permissiveness to Hepatitis B Virus Infection through Modulation of Sodium Taurocholate Cotransporting Polypeptide (NTCP) Expression* (2014) (52)
- Molecular evolutionary analyses implicate injection treatment for schistosomiasis in the initial hepatitis C epidemics in Japan. (2005) (51)
- Comparison between Subgenomic Replicons of Hepatitis C Virus Genotypes 2a (JFH-1) and 1b (Con1 NK5.1) (2005) (51)
- Hepatitis C virus infection in patients with clinically diagnosed alcoholic liver diseases (1996) (51)
- Adefovir Dipivoxil Monotherapy and Combination Therapy with Lamivudine for the Treatment of Chronic Hepatitis B in an Asian Population (2007) (51)
- High prevalance of TT virus infection in Japanese patients with liver diseases and in blood donors. (1999) (50)
- Hepatitis C virus types 7, 8 and 9 should be classified as type 6 subtypes. (1996) (50)
- Clinical significance of BRAF non-V600E mutations on the therapeutic effects of anti-EGFR monoclonal antibody treatment in patients with pretreated metastatic colorectal cancer: the Biomarker Research for anti-EGFR monoclonal Antibodies by Comprehensive Cancer genomics (BREAC) study (2017) (50)
- P0773 : The prevalence and the effect of HCV NS5A resistance associated variants in subjects with compensated cirrhosis treated with ledipasvir/sofosbuvir +/- RBV (2015) (50)
- Significance of antibody to the host cellular gene derived epitope GOR in chronic hepatitis C virus infection. (1993) (50)
- Association of IL28B variants with response to pegylated‐interferon alpha plus ribavirin combination therapy reveals intersubgenotypic differences between genotypes 2a and 2b (2011) (49)
- High frequency of hepatocellular carcinoma in Mongolia; association with mono‐, or Co‐infection with hepatitis C, B, and delta viruses (2006) (49)
- Serum CCL17 level becomes a predictive marker to distinguish between mild/moderate and severe/critical disease in patients with COVID-19 (2020) (48)
- Novel reporter system to monitor early stages of the hepatitis B virus life cycle (2015) (48)
- Full-length sequence of the genome of hepatitis C virus type 3a: comparative study with different genotypes. (1994) (47)
- Preponderance of hepatitis B virus genotype B contributes to a better prognosis of chronic HBV infection in Okinawa, Japan (2002) (47)
- Hepatitis C virus molecular epidemiology in Uzbekistan (2003) (47)
- Epidemiological and clinical evaluation of hepatitis B, hepatitis C, and delta hepatitis viruses in Tajikistan (2008) (47)
- Suppressive effect of oral administration of branched‐chain amino acid granules on oxidative stress and inflammation in HCV‐positive patients with liver cirrhosis (2008) (47)
- Influence of Hepatitis B Virus X and Core Promoter Mutations on Hepatocellular Carcinoma among Patients Infected with Subgenotype C2 (2007) (47)
- Microsatellite instability associated with hepatocarcinogenesis. (1999) (47)
- Virological and clinical characteristics on reactivation of occult hepatitis B in patients with hematological malignancy (2011) (47)
- Fatal reactivation of hepatitis B virus infection in a patient with adult T‐cell leukemia–lymphoma receiving the anti‐CC chemokine receptor 4 antibody mogamulizumab (2015) (47)
- Genetic Variation of the IL-28B Promoter Affecting Gene Expression (2011) (47)
- Genome-wide association study identified ITPA / DDRGK 1 variants reflecting thrombocytopenia in pegylated interferon and ribavirin therapy for chronic hepatitis C (2011) (46)
- Molecular evolutionary virology: its application to hepatitis C virus. (1994) (46)
- The use of monoclonal antibodies to define levels of cystatin C in normal human serum. (1989) (46)
- Novel Cell Culture-Adapted Genotype 2a Hepatitis C Virus Infectious Clone (2012) (46)
- Analysis of HCV genotypes from blood donors shows three new HCV type 6 subgroups exist in Myanmar. (2004) (46)
- Immunohistochemical studies of intrahepatic tumour necrosis factor alpha in chronic liver disease. (1990) (45)
- The impact of PNPLA3 and JAZF1 on hepatocellular carcinoma in non-viral hepatitis patients with type 2 diabetes mellitus (2016) (45)
- Genome‐wide association studies identify PRKCB as a novel genetic susceptibility locus for primary biliary cholangitis in the Japanese population (2017) (45)
- Quantification of serum hepatitis C virus core protein level in patients chronically infected with different hepatitis C virus genotypes. (1996) (45)
- De Novo Macrocyclic Peptide Inhibitors of Hepatitis B Virus Cellular Entry. (2018) (44)
- λ‐Interferons and the single nucleotide polymorphisms: A milestone to tailor‐made therapy for chronic hepatitis C (2010) (44)
- HLA-A*11:01:01:01, HLA-C*12:02:02:01-HLA-B*52:01:02:02, Age and Sex Are Associated With Severity of Japanese COVID-19 With Respiratory Failure (2021) (44)
- Longitudinal Study of Hepatitis Activity and Viral Replication before and after HBeAg Seroconversion in Chronic Hepatitis B Patients Infected with Genotypes B and C (2004) (44)
- Dynamic Epidemiology of Acute Viral Hepatitis in Japan (2010) (44)
- Adipostatins A and B, new inhibitors of glycerol-3-phosphate dehydrogenase. (1992) (44)
- Hepatitis C databases, principles and utility to researchers (2006) (44)
- Reliability of hepatitis C virus core antigen assay for detection of viremia in HCV genotypes 1, 2, 3, and 4 infected blood donors: A collaborative study between Japan, Egypt, and Uzbekistan (2004) (44)
- Simultaneous Quantification and Genotyping of Hepatitis B Virus for Genotypes A to G by Real-Time PCR and Two-Step Melting Curve Analysis (2006) (44)
- Genetic variability of hepatitis C virus in South Egypt and its possible clinical implication (2009) (44)
- Human immunodeficiency virus in Uzbekistan: epidemiological and genetic analyses. (2003) (43)
- Interleukin-34 as a fibroblast-derived marker of liver fibrosis in patients with non-alcoholic fatty liver disease (2016) (43)
- Measurement of hepatitis B virus core‐related antigen is valuable for identifying patients who are at low risk of lamivudine resistance (2006) (43)
- Study of needlestick accidents and hepatitis C virus infection in healthcare workers by molecular evolutionary analysis. (1997) (43)
- Development of a prediction model for 10-year risk of hepatocellular carcinoma in middle-aged Japanese: the Japan Public Health Center-based Prospective Study Cohort II. (2012) (42)
- Molecular tracing of Japan-indigenous hepatitis E viruses. (2006) (42)
- Chronic Hepatitis B Virus Infection: Disease Revisit and Management Recommendations. (2016) (42)
- Indoleamine‐2,3‐dioxygenase as an effector and an indicator of protective immune responses in patients with acute hepatitis B (2016) (42)
- No association for Chinese HBV-related hepatocellular carcinoma susceptibility SNP in other East Asian populations (2012) (42)
- Glycoproteomic discovery of serological biomarker candidates for HCV/HBV infection-associated liver fibrosis and hepatocellular carcinoma. (2013) (42)
- Early dynamics of hepatitis B virus in chimeric mice carrying human hepatocytes monoinfected or coinfected with genotype G (2007) (41)
- Tracing the history of hepatitis B virus genotype D in western Japan (2006) (41)
- Discrepancy between biochemical and virological responses to interferon-alpha in chronic hepatitis C. (1993) (41)
- Risk Factors and Seroprevalence of Hepatitis B Virus, Hepatitis C Virus, and Human Immunodeficiency Virus Infection in Uzbekistan (2002) (40)
- African origin of GB virus C/hepatitis G virus 1 (1998) (40)
- Serum aminotransferase level and the risk of hepatocellular carcinoma: a population-based cohort study in Japan (2009) (40)
- Hepatic stellate cells in hepatocellular carcinoma promote tumor growth via growth differentiation factor 15 production. (2020) (40)
- Isoflavone consumption and subsequent risk of hepatocellular carcinoma in a population‐based prospective cohort of Japanese men and women (2009) (40)
- Development of a TT Virus DNA Quantification System Using Real-Time Detection PCR (2000) (40)
- Relationship between Polymorphisms of the Inosine Triphosphatase Gene and Anaemia or Outcome after Treatment with Pegylated Interferon and Ribavirin (2011) (40)
- A study of genotypes, mutants and nucleotide sequence of hepatitis B virus in Pakistan (2011) (40)
- Natural history of bleeding risk in colonic diverticulosis patients: a long‐term colonoscopy‐based cohort study (2015) (39)
- Targeted Induction of Interferon-λ in Humanized Chimeric Mouse Liver Abrogates Hepatotropic Virus Infection (2013) (39)
- Loss of hepatitis C virus RNA after parturition in female patients with chronic HCV infection (2003) (39)
- TT virus infection among blood donors and patients with non-B, non-C liver diseases in Korea. (1999) (39)
- Quantitative assessment of liver fibrosis reveals a nonlinear association with fibrosis stage in nonalcoholic fatty liver disease (2017) (38)
- Multiple intra‐familial transmission patterns of hepatitis B virus genotype D in north‐eastern Egypt (2012) (38)
- Distribution and characteristics of hepatitis B virus genotype C subgenotypes in China * (2007) (38)
- Sofosbuvir–velpatasvir plus ribavirin in Japanese patients with genotype 1 or 2 hepatitis C who failed direct-acting antivirals (2018) (38)
- Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia (2008) (38)
- Understanding of HLA-conferred susceptibility to chronic hepatitis B infection requires HLA genotyping-based association analysis (2016) (38)
- Serum WFA+‐M2BP levels as a prognostic factor in patients with early hepatocellular carcinoma undergoing curative resection (2016) (37)
- Case–control study for the identification of virological factors associated with fulminant hepatitis B (2009) (37)
- Characteristics of hepatitis B virus genotype G coinfected with genotype H in chimeric mice carrying human hepatocytes. (2008) (37)
- Possible prediction of adverse reactions to pyrimidine chemotherapy from urinary pyrimidine levels and a case of asymptomatic adult dihydropyrimidinuria. (1996) (37)
- De novo infection of hepatitis B virus in patients with orthotopic liver transplantation: Analysis by determining complete sequence of the genome (2000) (36)
- LecT‐hepa, a glyco‐marker derived from multiple lectins, as a predictor of liver fibrosis in chronic hepatitis C patients (2012) (36)
- Geographic distribution and characteristics of genotype A hepatitis B virus infection in acute and chronic hepatitis B patients in Japan (2016) (36)
- Impact of occult hepatitis B virus infection on efficacy and prognosis of interferon‐α therapy for patients with chronic hepatitis C (2005) (36)
- Acute hepatitis C transmitted by needlestick accident despite short duration interferon treatment (1995) (36)
- Novel point mutations and mutational complexes in the enhancer II, core promoter and precore regions of hepatitis B virus genotype D1 associated with hepatocellular carcinoma in Saudi Arabia (2013) (36)
- Key HLA‐DRB1‐DQB1 haplotypes and role of the BTNL2 gene for response to a hepatitis B vaccine (2018) (36)
- The seroprevalence of hepatitis B and C in an Amerindian population in the southwestern Brazilian Amazon. (1999) (35)
- Functional association of cellular microtubules with viral capsid assembly supports efficient hepatitis B virus replication (2017) (35)
- Classification of hepatitis C virus into major types and subtypes based on molecular evolutionary analysis. (1995) (35)
- Relationships between serotypes and genotypes of hepatitis B virus: genetic classification of HBV by use of surface genes. (1995) (35)
- Development of Pancreatic Cancer, Disease-specific Mortality, and All-Cause Mortality in Patients with Nonresected IPMNs: A Long-term Cohort Study. (2016) (35)
- Transforming growth factor‐beta‐1 genetic polymorphism in Japanese patients with chronic hepatitis C virus infection (2003) (35)
- A weak association between occult HBV infection and non-B non-C hepatocellular carcinoma in Japan (2007) (35)
- Corrigendum: Production of infectious hepatitis C virus in tissue culture from a cloned viral genome (2005) (35)
- Differences of Hepatocellular Carcinoma Patients with Hepatitis B Virus Genotypes of Ba, Bj or C in Japan (2005) (35)
- Resistance Analyses of Japanese Hepatitis C‐Infected Patients Receiving Sofosbuvir or Ledipasvir/Sofosbuvir Containing Regimens in Phase 3 Studies (2016) (35)
- New genotype of hepatitis C virus in South Africa (1994) (34)
- Immunomodulatory Mechanism of Acyclic Nucleoside Phosphates in Treatment of Hepatitis B Virus Infection (2020) (34)
- Genotype, serum level of hepatitis C virus RNA and liver histology as predictors of response to interferon-alpha 2a therapy in Japanese patients with chronic hepatitis C. (2008) (34)
- A new genotype of TT virus (TTV) infection among Colombian native Indians (1999) (34)
- Hepatitis C virus genotypes 1 and 2 respond to interferon-alpha with different virologic kinetics. (1995) (34)
- Distribution of HBV genotypes among HBV carriers in Benin:phylogenetic analysis and virological characteristics of HBV genotype E. (2005) (34)
- Pyogenic granuloma of the stomach successfully treated by endoscopic resection after transarterial embolization of the feeding artery (2005) (34)
- Positive selection of core 70Q variant genotype 1b hepatitis C virus strains induced by pegylated interferon and ribavirin. (2010) (34)
- New Susceptibility and Resistance HLA-DP Alleles to HBV-Related Diseases Identified by a Trans-Ethnic Association Study in Asia (2014) (33)
- Slow Evolutionary Rate of GB Virus C/Hepatitis G Virus (1999) (33)
- Molecular evidence of father‐to‐child transmission of hepatitis B virus (2007) (33)
- Hepatitis G virus in immunosuppressed paediatric allograft recipients (1996) (33)
- Classifying genotype F of hepatitis B virus into F1 and F2 subtypes. (2005) (33)
- Host sphingolipid biosynthesis is a promising therapeutic target for the inhibition of hepatitis B virus replication (2011) (33)
- Quantification of red blood cell fragmentation by the automated hematology analyzer XE-2100 in patients with living donor liver transplantation. (2005) (32)
- Association of serum IFN-λ3 with inflammatory and fibrosis markers in patients with chronic hepatitis C virus infection (2015) (32)
- Genetic diversity of hepatitis B virus as an important factor associated with differences in clinical outcomes. (2007) (32)
- Novel Type of Hepatitis B Virus Mutation: Replacement Mutation Involving a Hepatocyte Nuclear Factor 1 Binding Site Tandem Repeat in Chronic Hepatitis B Virus Genotype E (2005) (32)
- Hepatitis B virus transmission pattern and vaccination efficiency in Uzbekistan (2008) (32)
- Risk of peptic ulcer bleeding associated with Helicobacter pylori infection, nonsteroidal anti‐inflammatory drugs, low‐dose aspirin, and antihypertensive drugs: A case‐control study (2015) (32)
- Effects of ruminal protozoa on cellulose degradation and the growth of an anaerobic ruminal fungus, Piromyces sp. strain OTS1, in vitro (1994) (32)
- Evolution of pathogenic viruses with special reference to the rates of synonymous and nonsynonymous substitutions. (1994) (31)
- Comparison of serum hepatitis C virus RNA concentration by branched DNA probe assay with competitive reverse transcription polymerase chain reaction as a predictor of response to interferon‐α therapy in chronic hepatitis C patients (1996) (31)
- Low incidence of hepatitis B virus reactivation and subsequent hepatitis in patients with chronic hepatitis C receiving direct‐acting antiviral therapy (2018) (31)
- APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy (2021) (31)
- Case report: development of hepatocellular carcinoma in a patient with chronic hepatitis C infection after a complete and sustained response to interferon-alpha. (1996) (31)
- Spread Times of Hepatitis C Virus Estimated by the Molecular Clock Differ among Japan, the United States and Egypt in Reflection of Their Distinct Socioeconomic Backgrounds (2005) (31)
- Hepatitis B and C virus infection and risk of lymphoid malignancies: A population-based cohort study (JPHC Study). (2015) (30)
- HBV genotypes in India: do they influence disease severity? (2009) (30)
- Molecular dissection of HBV evasion from restriction factor tetherin: A new perspective for antiviral cell therapy (2015) (30)
- Spontaneous regression of hepatocellular carcinoma: two case reports and a literature review. (2004) (30)
- Reactivation of hepatitis B virus (HBV) infection in adult T-cell leukemia–lymphoma patients with resolved HBV infection following systemic chemotherapy (2015) (29)
- Molecular Epidemiology and Genetic History of Hepatitis C Virus Subtype 3a Infection in Thailand (2013) (29)
- Mechanism of Entecavir Resistance of Hepatitis B Virus with Viral Breakthrough as Determined by Long-Term Clinical Assessment and Molecular Docking Simulation (2009) (29)
- Prevalence of Low Positive Anti‐HCV Antibodies in Blood Donors: Schistosoma mansoni Co‐Infection and Possible Role of Autoantibodies (2006) (29)
- Interferon‐α therapy for individuals with normal serum alanine aminotransferase levels before treatment (1997) (29)
- Usefulness and limitation of phylogenetic analysis for hepatitis C virus core region: application to isolates from Egyptian and Yemeni patients (2005) (29)
- Transmission of hepatitis B virus (HBV) genotypes among Japanese immigrants and natives in Bolivia. (2008) (28)
- Risk factors for adverse in-hospital outcomes in acute colonic diverticular hemorrhage. (2015) (28)
- Cytokine and chemokine signatures associated with hepatitis B surface antigen loss in hepatitis B patients. (2018) (28)
- Nationwide prospective and retrospective surveys for hepatitis B virus reactivation during immunosuppressive therapies (2016) (28)
- The first report of successful nasogastric Coca-Cola lavage treatment for bitter persimmon phytobezoars in Japan (2003) (28)
- Routes of transmission of hepatitis C virus in an endemic rural area of Japan. Molecular epidemiologic study of hepatitis C virus infection. (1997) (28)
- Genome-wide association study identified new susceptible genetic variants in HLA class I region for hepatitis B virus-related hepatocellular carcinoma (2018) (28)
- Cellular and humoral immune reactions against autoantigens and hepatitis C viral antigens in chronic hepatitis C. (1994) (28)
- Molecular epidemiology of hepatitis B virus in the United Republic of Tanzania (2006) (28)
- Reactivation of hepatitis B virus in a patient with adult T‐cell leukemia–lymphoma receiving the anti‐CC chemokine receptor 4 antibody mogamulizumab (2014) (28)
- Impact of viral load of hepatitis C on the incidence of hepatocellular carcinoma: A population-based cohort study (JPHC Study). (2011) (27)
- TT virus infection in patients with chronic hepatitis C virus infection--effect of primers, prevalence, and clinical significance. Hepatitis Interventional Therapy Group. (2000) (27)
- Prevalence and molecular epidemiology of GB virus C/hepatitis G virus infection in Mongolia (1997) (27)
- Hepatitis C virus serotype II responds more favorably to interferon-α therapy (1994) (27)
- The first report of successful nasogastric Coca-Cola lavage treatment for bitter persimmon phytobezoars in Japan. (2003) (27)
- Genotype and phylogenetic characterization of hepatitis B virus among multi-ethnic cohort in Hawaii. (2004) (27)
- Visceral Abdominal Obesity Measured by Computed Tomography is Associated With Increased Risk of Colonic Diverticulosis (2015) (27)
- Hepatitis B and C Virus Infection and Risk of Pancreatic Cancer: A Population-Based Cohort Study (JPHC Study Cohort II) (2015) (27)
- Genome‐Wide Association Study Identifies Risk Variants for Lichen Planus in Patients With Hepatitis C Virus Infection (2017) (27)
- LecT-Hepa: A triplex lectin-antibody sandwich immunoassay for estimating the progression dynamics of liver fibrosis assisted by a bedside clinical chemistry analyzer and an automated pretreatment machine. (2011) (27)
- Management of hepatitis B: Consensus of the Japan Society of Hepatology 2009 (2011) (26)
- Human leukocyte antigen variants and risk of hepatocellular carcinoma modified by hepatitis C virus genotypes: A genome‐wide association study (2018) (26)
- An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs (2021) (26)
- Effect of interferon-alpha and ribavirin therapy on serum GB virus C/hepatitis G virus (GBV-C/HGV) RNA levels in patients chronically infected with hepatitis C virus and GBV-C/HGV. (1997) (26)
- Chronic hepatitis C infection: Influence of the viral load, genotypes, and GBV‐C/HGV coinfection on the severity of the disease in a Brazilian population (2002) (26)
- Molecular epidemiology of hepatitis C virus genotypes in west Mexico. (2010) (26)
- Differential sensitivity of hepatitis C virus quasispecies to interferon-α therapy (1994) (26)
- A pilot randomized, controlled trial of the effect of iron depletion on long-term response to alpha-interferon in patients with chronic hepatitis C. (1998) (26)
- High stability of enzyme immunoassay for hepatitis C virus core antigen-evaluation before and after incubation at room temperature. (2003) (26)
- Direct hemoperfusion using a polymyxin B‐immobilized polystyrene column for COVID‐19 (2020) (26)
- Clinical characteristics and prevalence of GB virus C, SEN virus, and HFE gene mutation in Japanese patients with nonalcoholic steatohepatitis (2004) (26)
- Performance of two Real‐Time RT‐PCR assays for quantitation of hepatitis C virus RNA: Evaluation on HCV genotypes 1–4 (2010) (26)
- Abbott RealTime Hepatitis C Virus (HCV) and Roche Cobas AmpliPrep/Cobas TaqMan HCV Assays for Prediction of Sustained Virological Response to Pegylated Interferon and Ribavirin in Chronic Hepatitis C Patients (2008) (26)
- High-dose barium impaction therapy for the recurrence of colonic diverticular bleeding: a randomized controlled trial. (2015) (25)
- Systematic review with meta‐analysis: extrahepatic manifestations in chronic hepatitis C virus‐infected patients in East Asia (2019) (25)
- Hepatic necroinflammation and fibrosis in patients with genotypes Ba and C, core‐promoter and precore mutations (2005) (25)
- GB virus infection in patients with oral cancer and oral lichen planus. (1997) (25)
- GB virus C/hepatitis G virus infection among Colombian native Indians. (1998) (25)
- Early therapy with interferon for acute hepatitis C acquired through a needlestick. (1997) (25)
- Predicting relapse after cessation of Lamivudine monotherapy for chronic hepatitis B virus infection. (2004) (25)
- Application of a glycoproteomics-based biomarker development method: alteration in glycan structure on colony stimulating factor 1 receptor as a possible glycobiomarker candidate for evaluation of liver cirrhosis. (2014) (25)
- Gianotti-Crosti syndrome caused by acute hepatitis B virus genotype D infection. (2004) (25)
- An Association Between Core Mutations in Hepatitis B Virus Genotype F1b and Hepatocellular Carcinoma in Alaskan Native People (2018) (25)
- Molecular epidemiological study of hepatitis B virus infection in two different ethnic populations from the Solomon Islands (2007) (24)
- Cystic lymphangioma of the gall‐bladder: A case report (1995) (24)
- A randomized controlled trial of consensus interferon with or without lactoferrin for chronic hepatitis C patients with genotype 1b and high viral load. (2004) (24)
- Investigating an outbreak of acute viral hepatitis caused by hepatitis E virus variants in Karachi, South Pakistan (2011) (24)
- Detection of GB Virus‐C/Hepatitis G Virus RNA in Serum by Reverse Transcription Polymerase Chain Reaction (1997) (24)
- An infectious and selectable full‐length replicon system with hepatitis C virus JFH‐1 strain (2007) (24)
- Serum Levels of M2BPGi as Short-Term Predictors of Hepatocellular Carcinoma in Untreated Chronic Hepatitis B Patients (2017) (24)
- Genotyping of Hepatitis B Virus – Genotypes A to G by Multiplex Polymerase Chain Reaction (2008) (24)
- Molecular evolutionary analysis : its application in the study of hepatitis C virus. (1999) (23)
- Impact of discontinuing non-steroidal antiinflammatory drugs on long-term recurrence in colonic diverticular bleeding. (2015) (23)
- Tracing the evolution of hepatitis C virus in the United States, Japan, and Egypt by using the molecular clock. (2005) (23)
- Hepatitis B virus infection among residents of a nursing home for the elderly: Seroepidemiological study and molecular evolutionary analysis (2000) (23)
- Novel Hepatitis B Virus Genotype A Subtyping Assay That Distinguishes Subtype Aa from Ae and Its Application in Epidemiological Studies (2004) (23)
- Variations in the core promoter/pre‐core region in HBV genotype C in Japanese and Northern Vietnamese patients (2007) (23)
- Appropriate use of virtual touch quantification and FibroScan® M and XL probes according to the skin capsular distance (2016) (23)
- Whole-genome sequencing with long reads reveals complex structure and origin of structural variation in human genetic variations and somatic mutations in cancer (2021) (23)
- Tracing hepatitis C and Delta viruses to estimate their contribution in HCC rates in Mongolia (2007) (23)
- Peroxiredoxin 1, a Novel HBx-Interacting Protein, Interacts with Exosome Component 5 and Negatively Regulates Hepatitis B Virus (HBV) Propagation through Degradation of HBV RNA (2018) (23)
- Evaluation of Accumulation of Hepatitis C Virus Mutations in a Chronically Infected Chimpanzee: Comparison of the Core, E1, HVR1, and NS5b Regions (2001) (23)
- High-throughput and sensitive next-generation droplet digital PCR assay for the quantitation of the hepatitis C virus mutation at core amino acid 70. (2014) (22)
- Hepatitis C virus kinetics by administration of pegylated interferon-α in human and chimeric mice carrying human hepatocytes with variants of the IL28B gene (2012) (22)
- Differences of HBV genotypes and hepatocellular carcinoma in Asian countries (2007) (22)
- High levels of hepatitis B virus after the onset of disease lead to chronic infection in patients with acute hepatitis B. (2013) (22)
- Seroprevalence of hepatitis C virus infection and its genotype in Lanzhou, Western China (1995) (21)
- Molecular characterization of hepatitis B virus isolates from Zimbabwean blood donors (2011) (21)
- Heterogeneity in E2 region of GBV‐C/hepatitis G virus and hepatitis C virus (1998) (21)
- Mechanism of the dependence of hepatitis B virus genotype G on co‐infection with other genotypes for viral replication (2013) (21)
- A population-based cohort study for the risk factors of HCC among hepatitis B virus mono-infected subjects in Japan (2010) (21)
- Replication and infectivity of a novel genotype 1b hepatitis C virus clone (2012) (21)
- Hepatocyte Factor JMJD5 Regulates Hepatitis B Virus Replication through Interaction with HBx (2016) (21)
- Sequence variation and phylogenetic analysis of the 5‘ terminus of hepatitis G virus (1997) (20)
- Variations of hepatitis B virus core gene sequence in Western patients with chronic hepatitis B virus infection (1997) (20)
- Reactivation of hepatitis B virus in HBsAg-negative patients with multiple myeloma: two case reports (2010) (20)
- Influences on hepatitis B virus replication by a naturally occurring mutation in the core gene. (2007) (20)
- Development of real‐time detection direct test for hepatitis B virus and comparison with two commercial tests using the WHO international standard (2003) (20)
- Metagenomic identification of microbial signatures predicting pancreatic cancer from a multinational study. (2022) (20)
- Quantification of serum HCV core antigen by a fluorescent enzyme immunoassay in liver transplant recipients with recurrent hepatitis C--clinical and virologic implications. (1999) (20)
- Lenvatinib suppresses cancer stem-like cells in HCC by inhibiting FGFR 1-3 signaling, but not FGFR4 signaling. (2020) (19)
- Angiotensin–Converting Enzyme (ACE) 1 Gene Polymorphism and Phenotypic Expression of COVID-19 Symptoms (2021) (19)
- Ex vivo induction of IFN-λ3 by a TLR7 agonist determines response to Peg-IFN/Ribavirin therapy in chronic hepatitis C patients (2013) (19)
- Virological features of hepatitis B virus‐associated nephropathy in Japan (2007) (19)
- Strain‐dependent viral dynamics and virus‐cell interactions in a novel in vitro system supporting the life cycle of blood‐borne hepatitis C virus (2009) (19)
- A case-control study of response to lamivudine therapy for 2 years in Japanese and Chinese patients chronically infected with hepatitis B virus of genotypes Bj, Ba and C. (2006) (19)
- HBV/HCV Infection, Alcohol, Tobacco and Genetic Polymorphisms for Hepatocellular Carcinoma in Nagoya, Japan. (2000) (19)
- AETIOPATHOGENESIS OF HEPATOCELLULAR CARCINOMA (1996) (19)
- Lack of association between occult hepatitis B virus DNA viral load and aminotransferase levels in patients with hepatitis C virus‐related chronic liver disease (2004) (18)
- High sensitivity assay using serum sample for IL28B genotyping to predict treatment response in chronic hepatitis C patients (2010) (18)
- Hepatitis B caused by a hepatitis B surface antigen escape mutant (2008) (18)
- Hepatitis B virus genotypes in Alaska Native people with hepatocellular carcinoma : Preponderance of genotype F. Commentary (2007) (18)
- Health utilities using SF-6D scores in Japanese patients with chronic hepatitis C treated with sofosbuvir-based regimens in clinical trials (2017) (18)
- Molecular epidemiologic analysis of hepatitis C virus infection in injecting drug users with acute hepatitis C in Japan (2004) (18)
- What can be revealed by extending the sensitivity of HBsAg detection to below the present limit? (2008) (18)
- Role of HLA‐DP and HLA‐DQ on the clearance of hepatitis B virus and the risk of chronic infection in a multiethnic population (2017) (18)
- Molecular Evolution of Hepatitis Viruses (1999) (17)
- Development of an in vivo delivery system for CRISPR/Cas9-mediated targeting of hepatitis B virus cccDNA. (2020) (17)
- Plasma Levels of Adiponectin and Primary Liver Cancer Risk in Middle-Aged Japanese Adults with Hepatitis Virus Infection: A Nested Case–Control Study (2013) (17)
- Outcomes of living donor liver transplantation for hepatitis C virus‐positive recipients in Japan: results of a nationwide survey (2014) (17)
- Chronic hepatitis C complicated by Coombs-negative hemolytic anemia during interferon treatment. (1994) (17)
- Treatment of hepatitis C virus leads to economic gains related to reduction in cases of hepatocellular carcinoma and decompensated cirrhosis in Japan (2018) (17)
- Vertical transmission of hepatitis C. (1996) (17)
- Suppression of HBV replication by the expression of nickase- and nuclease dead-Cas9 (2017) (17)
- Comparison of complete sequences of hepatitis B virus genotype C between inactive carriers and hepatocellular carcinoma patients before and after seroconversion (2007) (17)
- Serotyping of hepatitis C virus in chronic type C hepatitis in Taiwan: Correlation with genotypes (1996) (16)
- Evolution of hepatitis B genotype C viral quasi-species during hepatitis B e antigen seroconversion. (2011) (16)
- High prevalence and phylogenetic analysis of TT-virus infection in Mongolia. (1999) (16)
- X chromosome contribution to the genetic architecture of primary biliary cholangitis. (2021) (16)
- Serologically defined genotypes of hepatitis C virus among Japanese patients with chronic hepatitis C. (1996) (16)
- Quality of life of Japanese patients with chronic hepatitis C treated with ledipasvir and sofosbuvir (2016) (15)
- Seroepidemiological study of hepatitis B virus markers in Japan. (2015) (15)
- Clearance of serum hepatitis C virus RNA after interferon therapy in relation to virus genotype. (2008) (15)
- Molecular evolutionary analysis of the complete nucleotide sequence of hepatitis B virus (HBV) in a case of HBV infection acquired through a needlestick accident. (2000) (15)
- Ultra-high sensitivity HBsAg assay can diagnose HBV reactivation following rituximab-based therapy in patients with lymphoma. (2020) (15)
- Efficacy and safety of interferon treatment in elderly patients with chronic hepatitis C in Japan: A retrospective study using the Japanese Interferon Database (2015) (15)
- Combined identifying granuloma and biopsy culture is useful for diagnosing intestinal tuberculosis (2015) (15)
- Seroprevalence of hepatitis B virus, hepatitis C virus and GB virus-C infections in Siberia (1999) (15)
- Human Gut Microbiota and Its Metabolites Impact Immune Responses in COVID-19 and Its Complications (2022) (15)
- New combination test for hepatitis C virus genotype and viral load determination using Amplicor GT HCV MONITOR test v2.0. (2005) (14)
- Evaluation of anti-hepatitis E virus (HEV) immunoglobulin A in a serological screening for HEV infection (2007) (14)
- Discovery of critical host factor, IL‐28B, associated with response to hepatitis C virus treatment (2012) (14)
- Recurrence and prognosis of patients emergently hospitalized for acute esophageal variceal bleeding: A long‐term cohort study (2016) (14)
- Construction of complete Tupaia belangeri transcriptome database by whole-genome and comprehensive RNA sequencing (2019) (14)
- Development of specific and quantitative real‐time detection PCR and immunoassays for λ3‐interferon (2012) (14)
- Does Genetic Predisposition Contribute to the Exacerbation of COVID-19 Symptoms in Individuals with Comorbidities and Explain the Huge Mortality Disparity between the East and the West? (2021) (14)
- The rs 8099917 Polymorphism , When Determined by a Suitable Genotyping Method , Is a Better Predictor for Response to Pegylated Alpha Interferon / Ribavirin Therapy in Japanese Patients than Other Single Nucleotide Polymorphisms Associated with Interleukin-28 B † (2011) (14)
- Serum Wisteria Floribunda Agglutinin-Positive Sialylated Mucin 1 as a Marker of Progenitor/Biliary Features in Hepatocellular Carcinoma (2017) (14)
- Genotype of GB virus C/hepatitis G virus by molecular evolutionary analysis. (1997) (14)
- Investigating the hepatitis B virus life cycle using engineered reporter hepatitis B viruses (2017) (14)
- Relationship between the presence of circulating anti-GOR and hepatitis C viremia/genotype. (1995) (14)
- Interferon-free therapy with direct acting antivirals for HCV/HIV-1 co-infected Japanese patients with inherited bleeding disorders (2017) (14)
- Plasma Isoflavones and Risk of Primary Liver Cancer in Japanese Women and Men with Hepatitis Virus Infection: A Nested Case–Control Study (2014) (14)
- Evaluation of Coronavirus Disease 2019 Severity Using Urine Biomarkers (2020) (14)
- Hepatitis B virus reactivation in patients with rheumatoid arthritis: Analysis of the National Database of Japan (2018) (14)
- TT virus infection among IVDUs in south western China. (1999) (14)
- Interferon-alpha therapy in patients dually infected with hepatitis C virus and GB virus C/hepatitis G virus--virological response of HGV and pretreatment HGV viremia level. (1997) (13)
- HCV phylogenetic signature and prevalence of pretreatment NS5A and NS5B NI‐Resistance associated substitutions in HCV‐Infected patients in Mainland China (2018) (13)
- GB virus C/hepatitis G virus infection among Korean patients with liver diseases and general population. (1997) (13)
- Regional disparities in interferon therapy for chronic hepatitis C in Japan: a nationwide retrospective cohort study (2015) (13)
- Virological and Clinical Characteristics of Hepatitis B Virus Genotype A (2017) (13)
- Variations of hepatitis B virus precore/core gene sequence in acute and fulminant hepatitis B (1994) (13)
- A novel glycobiomarker, Wisteria floribunda agglutinin macrophage colony‐stimulating factor receptor, for predicting carcinogenesis of liver cirrhosis (2016) (13)
- Biochemical response to interferon therapy correlates with interferon sensitivity‐determining region in hepatitis C virus genotype 1b infection (2001) (13)
- Analysis of HBV Genomes Integrated into the Genomes of Human Hepatoma PLC/PRF/5 Cells by HBV Sequence Capture-Based Next-Generation Sequencing (2020) (13)
- Novel Evidence of HBV Recombination in Family Cluster Infections in Western China (2012) (13)
- Vertical transmission of hepatitis C through three generations (1996) (13)
- Molecular epidemiology of hepatitis C virus infection in an area endemic for community-acquired acute hepatitis C. (1999) (13)
- High prevalence of GB virus C/hepatitis G virus infection among the Jewish population in Uzbekistan. (1997) (13)
- Increasing genetic diversity of hepatitis C virus in haemophiliacs with human immunodeficiency virus coinfection. (2007) (13)
- Production of Infectious Chimeric Hepatitis C Virus Genotype 2b Harboring Minimal Regions of JFH-1 (2011) (13)
- Prospective Nationwide Observational Study of Hepatitis B Virus (HBV) DNA Monitoring and Preemptive Antiviral Therapy for HBV Reactivation in Patients with B-Cell Non-Hodgkin Lymphoma Following Rituximab Containing Chemotherapy: Results of Interim Analysis. (2012) (12)
- Biological properties of purified recombinant HCV particles with an epitope-tagged envelope. (2010) (12)
- Lack of Integrated TT Virus (TTV) Genomes Into Cellular DNA in Infected Human Hematopoietic Cells (2000) (12)
- A reduction in selective immune pressure during the course of chronic hepatitis C correlates with diminished biochemical evidence of hepatic inflammation. (2007) (12)
- Timing of interferon therapy and sources of infection in patients with acute hepatitis C. (2006) (12)
- Multicenter cooperative case survey of hepatitis B virus reactivation by chemotherapeutic agents (2015) (12)
- Neutrophil chemotactic N-acetyl peptides from the calpain small subunit are also chemotactic for immunocytes. (1995) (12)
- Impact of HIV Infection on Colorectal Tumors: A Prospective Colonoscopic Study of Asian Patients (2014) (12)
- Molecular evolutionary analysis predicts the incidence of hepatocellular carcinoma in the United States and Japan (2004) (12)
- Model incorporating the ITPA genotype identifies patients at high risk of anemia and treatment failure with pegylated‐interferon plus ribavirin therapy for chronic hepatitis C (2013) (12)
- GB virus C (GBV-C)/hepatitis G virus (HGV) infection among intravenous drug users in Japan. (1997) (12)
- Regression of esophageal papillomatous polyposis caused by high-risk type human papilloma virus (2003) (11)
- Using decision tree learning to predict the responsiveness of hepatitis C patients to drug treatment (2012) (11)
- Effects of HLA-DPB1 genotypes on chronic hepatitis B infection in Japanese individuals. (2015) (11)
- Novel findings for the development of drug therapy for various liver diseases: Genetic variation in IL-28B is associated with response to the therapy for chronic hepatitis C. (2011) (11)
- Hepatitis B virus genotype G is an extremely rare genotype in Japan. (2004) (11)
- Different Gastric Mucosa and CagA Status of Patients in India and Japan Infected with Helicobacter pylori (2014) (11)
- N‐Terminal PreS1 Sequence Regulates Efficient Infection of Cell‐Culture–Generated Hepatitis B Virus (2020) (11)
- Specific mutations of basal core promoter are associated with chronic liver disease in hepatitis B virus subgenotype D1 prevalent in Turkey (2013) (11)
- IFN-λ3 as a host immune response in acute hepatitis E virus infection. (2019) (11)
- Clinical significance of hepatitis B virus (HBV)-DNA monitoring to detect HBV reactivation after systemic chemotherapy. (2011) (11)
- A prospective trial of vaccine to prevent hepatitis B virus reactivation after hematopoietic stem cell transplantation (2020) (11)
- Identification and phylogenetic analysis of hepatitis C virus in forensic blood samples obtained from injecting drug users. (2007) (10)
- Highly Sensitive Glycan Profiling of Hepatitis B Viral Particles and a Simple Method for Dane Particle Enrichment. (2018) (10)
- Case Report: Changes in Cytokine Kinetics During the Course of Disease in a Japanese Patient With Multisystem Inflammatory Syndrome in Children (2021) (10)
- Different natural courses of chronic hepatitis B with genotypes B and C after the fourth decade of life. (2007) (10)
- Accidental exposure to HCV antibody‐positive blood in hospital and pre‐emptive one‐shot interferon alpha‐2b treatment (2007) (10)
- Association Between High Levels of Hepatitis B Core Antibody and Seroclearance of Hepatitis B e Antigen in Individuals With Chronic Hepatitis B Virus Infection. (2019) (10)
- 364 An Integrated Safety, Efficacy, and Virology Analysis of >500 Patients With Compensated Cirrhosis Treated With Ledipasvir/Sofosbuvir With or Without Ribavirin (2015) (10)
- GB virus C/hepatitis G virus infection among patients with hepatocellular carcinoma in the inshore area of the Yangtze river, China (1998) (10)
- Pyrimidotriazine derivatives as selective inhibitors of HBV capsid assembly. (2019) (10)
- Natural history of outpatient-onset ischemic colitis compared with other lower gastrointestinal bleeding: a long-term cohort study (2015) (10)
- Hepatitis G virus infection in renal transplant recipients (1999) (10)
- ITPA genetic variants influence efficacy of PEG‐IFN/RBV therapy in older patients infected with HCV genotype 1 and favourable IL28B type (2014) (9)
- Population-level metagenomics uncovers distinct effects of multiple medications on the human gut microbiome. (2022) (9)
- Lack of association between TTV viral load and aminotransferase levels in patients with hepatitis C or non-B-C. (2000) (9)
- Relationship between histological prognosis of chronic hepatitis C and amount of hepatitis C virus core protein in serum (2000) (9)
- Effect of interferon therapy on Japanese chronic hepatitis C virus patients with anti‐liver/kidney microsome autoantibody type 1 (2001) (9)
- Significance of hepatic expression of hepatitis C viral antigens in chronic hepatitis C (1995) (9)
- Negative regulation of hepatitis B virus replication by forkhead box protein A in human hepatoma cells (2015) (9)
- A patient in whom only hepatitis B virus (HBV) was thought to have been contracted, by kissing, from a same-sex partner coinfected with HBV and human immunodeficiency virus-1 (2003) (9)
- Identification of a novel 23 kDa protein encoded by putative open reading frame 2 of TT virus (TTV) genotype 1 different from the other genotypes (2000) (9)
- Frequency and Characteristics of Occult Hepatitis B Infection Among Hepatocellular Carcinoma Patients in Japan. (2018) (9)
- [Intestinal colonization and nosocomial spread of Clostridium difficile in pediatric cancer patients under long-term hospitalization]. (2008) (9)
- Serologic testing of randomly selected children after hepatitis B vaccination: a cross-sectional population-based study in Lao People’s Democratic Republic (2019) (9)
- Characterization of infectious hepatitis C virus from liver-derived cell lines. (2008) (9)
- Serotypes, genotypes and levels of hepatitis C viremia in pregnant women in Taiwan. (1996) (8)
- Prevalence of Amino acid mutation in hepatitis C virus core region among Japanese volunteer blood donors (2011) (8)
- Review article: HCV ? STAT-C era of therapy (2010) (8)
- Impact of Immune Reconstitution-induced Hepatic Flare on HBsAg Loss in HBV/HIV-1-Coinfected Patients. (2020) (8)
- Enterovesical fistula complication in B-cell-type lymphoma of the small intestine (2004) (8)
- Prevalence of hepatitis C virus infection in Nanjing, Southern China (1997) (8)
- Variations of hepatitis C virus NS5B sequence (nucleotides 8261–8566) do not correlate with response to interferon‐α therapy (1995) (8)
- Factors responsible for the discrepancy between IL28B polymorphism prediction and the viral response to peginterferon plus ribavirin therapy in Japanese chronic hepatitis C patients (2012) (8)
- Human IgM Monoclonal Antibody to Ganglioside GM2 and Complement Suppress Virus Propagation in Ex Vivo Cultures of Lymphocytes from HIV‐1 Infected Patients (1999) (8)
- IL28B Polymorphisms and Clinical Implications for Hepatitis C Virus Infection in Uzbekistan (2014) (8)
- [Evaluation of hepatitis B virus genotyping EIA kit]. (2009) (8)
- Phenotype-dependent production of des-γ-carboxy prothrombin in hepatocellular carcinoma (2011) (7)
- [Analysis of some viral infections, transmitted by parenteral and sexual routes, in the Republic of Azerbaijan]. (1999) (7)
- Association of serum interferon‐λ3 levels with hepatocarcinogenesis in chronic hepatitis C patients treated with direct‐acting antiviral agents (2019) (7)
- Is antiviral prophylaxis necessary to prevent hepatitis B virus (HBV) reactivation in patients with HBV-resolved infection receiving rituximab-containing chemotherapy? (2013) (7)
- Pre-S proteins in chronic hepatitis B virus infection: markers of active viral infection. (1989) (7)
- Erratum: Production of infectious hepatitis C virus in tissue culture from a cloned viral genome (Nature Medicine (2005) 11 (791-796)) (2005) (7)
- Prevalence of TT Virus and GBV-C Infections among Patients with Liver Diseases and the General Population in Shanghai, China (2004) (7)
- GB virus C/hepatitis G virus infection among patients with hepatocellular carcinoma (1997) (7)
- Development of new IL28B genotyping method using Invader Plus assay (2012) (7)
- Prognostic indicators of breakthrough hepatitis during lamivudine monotherapy for chronic hepatitis B virus infection (2004) (7)
- Easy‐to‐use phylogenetic analysis system for hepatitis B virus infection (2011) (7)
- Impact of daily high-dose IFNalpha-2b plus ribavirin combination therapy on reduction of ALT levels in patients with chronic hepatitis C with genotype 1 and high HCV RNA levels. (2005) (7)
- Phylogenetic tree‐based epidemiological analysis of hepatitis C virus transmission in a region of Japan with a high prevalence of infection (1996) (7)
- Cross-species transmission of gibbon and orangutan hepatitis B virus to uPA/SCID mice with human hepatocytes. (2011) (7)
- Hepatitis C virus serotype II responds more favorably to interferon-alpha therapy. (1994) (7)
- [Fundamental and clinical evaluation of hepatitis B virus core-related antigen assay by LUMIPULSE f]. (2006) (7)
- Expression of pre-S1, pre-S2, S and X peptides in relation to viral replication in livers with chronic hepatitis B. (2008) (7)
- Modulation of hepatitis B virus infection by epidermal growth factor secreted from liver sinusoidal endothelial cells (2020) (7)
- Full-Genome Analysis of Hepatitis C Virus in Japanese and Non-Japanese Patients Coinfected With HIV-1 in Tokyo (2019) (7)
- Suppressor of cytokine signal 3 and IL28 genetic variation predict the viral response to peginterferon and ribavirin (2011) (7)
- Differential sensitivity of hepatitis C virus quasispecies to interferon-alpha therapy. (1994) (7)
- Frequency and Characteristics of Occult Hepatitis B Infection Among Hepatocellular Carcinoma Patients in Japan. (2018) (6)
- Strong alkaline electrolyzed water efficiently inactivates SARS-CoV-2, other viruses, and Gram-negative bacteria (2021) (6)
- Histopathological factors affecting the extraction of high quality genomic DNA from tissue sections for next-generation sequencing. (2019) (6)
- Pro‐angiogenic TIE‐2‐expressing monocytes/TEMs as a biomarker of the effect of sorafenib in patients with advanced hepatocellular carcinoma (2017) (6)
- Prophylactic antiviral therapy for hepatitis B virus surface antigen‐positive patients with diffuse large B‐cell lymphoma treated with rituximab‐containing chemotherapy (2021) (6)
- Clonal selection of HIV type 1 variants associated with resistance to foscarnet in vitro: confirmation by molecular evolutionary analysis. (1997) (6)
- Genome-Wide Association Study Reveals Host Genetic Factors for Liver Diseases (2013) (6)
- A human PSMB11 variant affects thymoproteasome processing and CD8+ T cell production. (2017) (6)
- Smoking is a risk factor for development of adult T-cell leukemia/lymphoma in Japanese human T-cell leukemia virus type-1 carriers (2016) (6)
- Optimal titer of anti‐HBs in blood components derived from donors with anti‐HBc (2019) (6)
- Extensive gut virome variation and its associations with host and environmental factors in a population-level cohort (2022) (6)
- Abdominal Fat Accumulation, as Measured by Computed Tomography, Increases the Risk of Ischemic Colitis: A Retrospective Case–Control Study (2015) (6)
- Anti‐viral effects of interferon‐λ3 on hepatitis B virus infection in cell culture (2019) (6)
- Interferon-alpha therapy exerts selective pressure on hepatitis C virus quasispecies equilibrium. (1999) (6)
- Liver Transplantation-Associated de novo Hepatitis B Virus Infection: Application of Molecular Evolutionary Analysis (2002) (6)
- Sexual transmission of Hepatitis C virus (1994) (6)
- Recommendation of lamivudine‐to‐entecavir switching treatment in chronic hepatitis B responders: Randomized controlled trial (2011) (6)
- Tracing the Spread of Hepatitis C Virus in Turkey: A Phylogenetic Analysis (2013) (6)
- Variations in the Viral NS5B Region in Japanese Patients with Chronic Hepatitis C Virus Genotype 1b Infection (2006) (6)
- Genetic association of IL17 and the importance of ABO blood group antigens in saliva to COVID-19 (2022) (6)
- Hepatitis B virus vaccination‐related seroprevalence among health‐care personnel in a Japanese tertiary medical center (2016) (6)
- Features of resistance-associated substitutions after failure of multiple direct-acting antiviral regimens for hepatitis C (2020) (5)
- Japanese case of hepatitis B virus genotypes C/D hybrid (2007) (5)
- Genotype distribution in Nagoya and new genotype (genotype 3a) in Japanese patients with hepatitis C virus (1995) (5)
- Hepatitis B Virus Genotype Study in West Africa Reveals an Expanding Clade of Subgenotype A4 (2021) (5)
- MGeND: an integrated database for Japanese clinical and genomic information (2019) (5)
- HIV-1 infection, but not syphilis or HBV infection, is a strong risk factor for anorectal condyloma in Asian population: a prospective colonoscopy screening study. (2015) (5)
- Intraspousal transmission of GB virus C/hepatitis G virus in an hepatitis C virus hyperendemic area in Japan (1999) (5)
- Analysis of the core and E1 envelope region sequences of a novel variant of hepatitis C virus obtained in Indonesia (2005) (5)
- Transmission dynamics of SARS-CoV-2 on the Diamond Princess uncovered using viral genome sequence analysis (2021) (5)
- A thymine–adenine dinucleotide repeat polymorphism near IL28B is associated with spontaneous clearance of hepatitis C virus (2015) (5)
- PCR‐probe capture hybridization assay and statistical model for SEN virus prevalence estimation (2004) (4)
- [Evaluation and application of a newly developed highly sensitive HBsAg chemiluminescent enzyme immunoassay for chronic hepatitis B patients]. (2010) (4)
- Frequent Detection of Hepatitis C Virus Subtype 3a (HCV‐3a) Isolates in Thailand by PCR Using Subtype‐Specific Primers (1995) (4)
- HCV RNA monitoring for tailored regimens of interferon therapy in hepatitis C. (1995) (4)
- Screening siRNAs against host glycosylation pathways to develop novel antiviral agents against hepatitis B virus (2020) (4)
- Association of ITPA gene variation and serum ribavirin concentration with a decline in blood cell concentrations during pegylated interferon-alpha plus ribavirin therapy for chronic hepatitis C (2013) (4)
- Real‐world safety and effectiveness of ledipasvir/sofosbuvir for the treatment of chronic hepatitis C virus genotype 1 in Japan (2020) (4)
- Genotype 2 a Hepatitis C Virus Subgenomic Replicon Can Replicate in HepG 2 and IMY-N 9 cells (2004) (4)
- Prevalence of equine hepacivirus infection in Mongolia. (2020) (4)
- Impact of Immune Reconstitution-Induced Hepatic Flare on Hepatitis B Surface Antigen Loss in Hepatitis B Virus/Human Immunodeficiency Virus-1 Coinfected Patients (2020) (4)
- Determination of HCV quasispecies by cloning and sequencing. (1999) (4)
- A Glycomarker for Short-term Prediction of Hepatocellular Carcinoma: A Longitudinal Study With Serial Measurements (2018) (4)
- Asian Pacific Association for Study of the Liver (APASL) (2003) (4)
- [Relation between HCV genotype and serum HCV RNA level as predictors of response to interferon-alfa 2b therapy in chronic hepatitis C]. (1994) (4)
- Impact of determination of hepatitis B virus subgenotype and pre‐core/core‐promoter mutation for the prediction of acute exacerbation of asymptomatic carriers (2009) (4)
- [Defective short variants of S region in chronic HBV carriers]. (1993) (4)
- Amino acid substitutions in NS5A region of GB virus C and response to interferon therapy (1999) (4)
- High Prevalence of Chronic Viral Hepatitis and Liver Fibrosis among Mongols in Southern California (2020) (4)
- Validity of administrative database detection of previously resolved hepatitis B virus in Japan (2019) (4)
- Pretreatment serum levels of interferon-gamma-inducible protein-10 are associated with virologic response to telaprevir-based therapy. (2016) (3)
- Prophylactic antiviral therapy for HBsAg-positive patients with DLBCL treated with rituximab-containing chemotherapy. (2021) (3)
- Phylogenetic and phylodynamic analyses of hepatitis C virus subtype 1a in Okinawa, Japan (2018) (3)
- [Primary adenosquamous carcinoma of the liver presenting with hematochezia due to tumor invasion of the colon]. (2013) (3)
- HERC5 E3 ligase mediates ISGylation of hepatitis B virus X protein to promote viral replication. (2021) (3)
- Clarification of interspousal hepatitis C virus infection in acute hepatitis C patients by molecular evolutionary analyses: Consideration on sexual and non‐sexual transmission between spouses (2011) (3)
- Hepatitis B Virus Core-related Antigens as a Marker for Monitoring of Chronic Hepatitis B Infection (2007) (3)
- Universal vaccination of hepatitis B virus vaccine (2012) (3)
- Importance of HBsAg recognition by HLA molecules as revealed by responsiveness to different hepatitis B vaccines (2021) (3)
- [Prevention of vertical transmission of Group B Streptococcus]. (2005) (3)
- Clinical significance of BRAF non-V600E mutations on the therapeutic effects of anti-EGFR monoclonal antibody treatment in patients with pretreated metastatic colorectal cancer: the Biomarker Research for anti-EGFR monoclonal Antibodies by Comprehensive Cancer genomics (BREAC) study (2017) (3)
- Analysis of conserved ambisense sequences within GB virus C. (1998) (3)
- Clinical evaluation of intramuscular administration of natural interferon-gamma in the treatment of chronic hepatitis B. (1995) (3)
- Human immunodeficiency virus and hepatitis B genotype G/A2 recombinant co-infection: a case study (2016) (3)
- Outcome of nucleos(t)ide analog intervention in patients with preventive or on‐demand therapy for hepatitis B virus reactivation (2020) (3)
- 1169 GENETIC POLYMORPHISM IN IL28B PREDICTS NULL VIROLOGICAL RESPONSE TO PEGYLATED-INTERFERON PLUS RIBAVIRIN THERAPY FOR CHRONIC HEPATITIS C (2010) (3)
- Nucleotide sequence of the core region of hepatitis C virus in Pakistan and Bangladesh and the geographic characterisation of hepatitis C virus in South Asia (1994) (3)
- Recent trends in acute hepatitis B in Japan (2006) (3)
- Virological Factors Associated with the Occurrence of HBV Reactivation in Patients with Resolved HBV Infection Analyzed through Ultradeep Sequencing. (2019) (3)
- FGFR2 maintains cancer cell differentiation via AKT signaling in esophageal squamous cell carcinoma (2021) (3)
- Incidence of anti-HTLV-1 antibody in liver disease (1992) (3)
- Estimation of two real-time RT-PCR assays for quantitation of hepatitis C virus RNA during PEG-IFN plus ribavirin therapy by HCV genotypes and IL28B genotype (2013) (3)
- 726 GENOME-WIDE ASSOCIATION STUDY IDENTIFIES GENETIC VARIANTS IN THE HLA-DP LOCUS ASSOCIATED WITH CHRONIC HEPATITIS B (2010) (3)
- [Risk of hepatitis C virus infection by needlestick among medical employees]. (1991) (3)
- Hepatitis C Virus Genotypes and Their Evolution (2016) (3)
- Pulsed field gel electrophoresis analysis conditions for molecular epidemiological identification of vertical Group B Streptococcus infection. (2005) (3)
- Nucleotide and amino acid diversities of E2/NS1 hypervariable region 1 and response to interferon therapy in patients with chronic hepatitis C virus infection (1998) (3)
- Reduced therapeutic effect of antiviral drugs in patients with hepatitis B virus reactivation after hematopoietic stem cell transplantation (2018) (3)
- Transmission of Hepatitis C Virus Through Needlestick Accidents in Health Care Workers (1994) (3)
- Differences in hepatitis C virus core protein processing among genotypes 1 and 2. (2004) (2)
- Interferon lambda 3 in the early phase of coronavirus disease‐19 can predict oxygen requirement (2022) (2)
- 1178 GENOME-WIDE ASSOCIATION STUDY IDENTIFIES IL28B ASSOCIATED WITH RESPONSE TO PEGYLATED INTERFERON-ALFA AND RIBAVIRIN THERAPY FOR JAPANESE PATIENTS WITH CHRONIC HEPATITIS C (2010) (2)
- ACUTE VIRAL HEPATITIS EPIDEMIC CAUSED BY HEPATITIS E VIRUS VARIANTS: VIGILANT SAMPLING AND APT TEST INFLUENCE DIAGNOSIS (2009) (2)
- Multi-center clinical studies for strategies to improve patients' accessibility to peginterferon therapy: Consideration based on both prospective study and retrospective study (2010) (2)
- A case report of HBV carrier with seronegative for anti-HBc caused by vertical transmission (1987) (2)
- [Clinical manifestations of hepatitis B virus genotype]. (2006) (2)
- A Fatal Breakthrough COVID-19 Case Following Bendamustine-Rituximab Therapy (2022) (2)
- Sustained virologic response by ledipasvir/sofosbuvir reduces the incidence of hepatocellular carcinoma in Japanese patients with HCV genotype 1 infection. - Comparison with Simeprevir with peginterferon plus ribavirin (2017) (2)
- Pretreatment prediction of the outcome of response-guided peginterferon-α and ribavirin therapy for chronic hepatitis C (2014) (2)
- Orchestration of Intracellular Circuits by G Protein-Coupled Receptor 39 for Hepatitis B Virus Proliferation (2020) (2)
- Establishment of infectious genotype 4 cell culture-derived hepatitis C virus. (2019) (2)
- Usefulness of uracil loading test for detecting 5-fluorouracil metabolic enzyme deficiencies in humans (2000) (2)
- Lack of anti‐GOR antibody among subjects with GB virus C/hepatitis G virus RNA (1998) (2)
- Case Report: Ciclosporin A for Refractory Multisystem Inflammatory Syndrome in Children (2022) (2)
- Effects of nucleos(t)ide analogs on hepatitis B surface antigen reduction with interferon‐lambda 3 induction in chronic hepatitis B patients (2022) (2)
- [Relationship between Shenzhen HBV genotype and precore/core promoter mutation and antiviral effects]. (2006) (2)
- Hepatitis B Virus Genotypes (2016) (2)
- A case of acute hepatitis C in which transmission of HCV strain from a patient with chronic hepatitis C was demonstrated (2006) (2)
- Effects of Combination Therapy with Direct Hemoperfusion Using Polymyxin B-Immobilized Fiber and Oral Vancomycin on Fulminant Pseudomembranous Colitis with Septic Shock (2007) (2)
- O-glycosylated HBsAg peptide can induce specific antibody neutralizing HBV infection. (2021) (2)
- [Present state and the future direction of HBV vaccine]. (2012) (1)
- Amino acid substitutions in NS5A region of GB virus C and response to interferon therapy. (1999) (1)
- Reimbursement policies in Asia-Pacific for chronic Hepatitis B (2009) (1)
- Development of an assay system for large scale analysis of HLA class II-binding peptides. (2017) (1)
- [Clinical and virologic characteristics and treatment for chronic hepatitis B: relation with HBV genotypes]. (2005) (1)
- Molecular classification of hepatitis C virus (1993) (1)
- Increase in platelet count based on inosine triphosphatase genotype during interferon beta plus ribavirin combination therapy (2012) (1)
- [Molecular evolution and genotype classification of TT virus]. (1999) (1)
- Cost-Effectiveness Modeling Study of boceprevir for the treatment of patients with genotype 1 chronic hepatitis C virus infection in Hong Kong (2013) (1)
- Evolution of pathogenic viruses with special reference to the rates of synonymous and nonsynonymous substitutions (1994) (1)
- Cost-effectiveness of managing HBV reactivation in patients with resolved HBV infection treated with anti-CD20 antibody for B-cell non-Hodgkin lymphoma (2022) (1)
- Genome-wide copy number variation analysis of hepatitis B infection in a Japanese population (2021) (1)
- Establishment of a Practical Workflow Using a Next Generation Sequencer to Search for Novel SNPs Associated with the Anti-HCV Treatment Response (2014) (1)
- Use of nucleoside analogs in patients with chronic hepatitis B in Nepal: A prospective cohort study in a single hospital (2015) (1)
- Strategy for preventing hepatitis B reactivation in patients with resolved hepatitis B virus infection after rituximab‐containing chemotherapy (2014) (1)
- A case of PBC following delivery in 24 year old woman. (1987) (1)
- Optimization for the detection of hepatitis C viral (HCV) antigens in liver. (1993) (1)
- Form 2 k / 1 b Hepatitis C Virus Circulating Recombinant Origin and Evolution of the Unique (2012) (1)
- Changing concept of hepatitis B virus (2009) (1)
- Establishment of monoclonal antibodies broadly neutralize infection of hepatitis B virus (2022) (1)
- [A case of HBsAg positive liver cirrhosis who died after withdrawal of steroid]. (1992) (1)
- No increased risk of hepatocellular carcinoma after eradication of hepatitis C virus by direct-acting antivirals, compared with interferon-based therapy. (2022) (1)
- Hepatitis B genotypes and long-term lamivudine therapy (2003) (1)
- [Why so high incidence of HCC in Japan?]. (2009) (1)
- Mutation in the Box a Increases the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Virus Genotype C Infection (2005) (1)
- A case of autoimmune hepatitis superimposed by Ukon-induced liver injury (2005) (1)
- Prevalence and incidence of HIV-1 infection in a community-based men who have sex with men (MSM) cohort in Ulaanbaatar, Mongolia. (2020) (1)
- In vitro replication competence of a hepatitis B genotype D/A recombinant virus: dissimilar biological behaviour regarding its parental genotypes. (2013) (1)
- [False positive serum des-gamma-carboxy prothrombin after resection of hepatocellular carcinoma]. (2007) (1)
- [Evaluation of high-sensitivity HBsAg quantitative assay for HBV genotype]. (2009) (1)
- Response to the letter by Dr. Naoya Yamada, and Dr. Koichi Mizuta regarding our manuscript: “Mac-2 binding protein glycan isomer (M2BPGi) is a new serum biomarker for assessing liver fibrosis: more than a biomarker of liver fibrosis” (2018) (1)
- [Clinical examinations based on nucleic acids of hepatitis viruses]. (2006) (1)
- [Clinical evaluation of a novel HBsAg quantitative assay]. (2007) (1)
- IDDF2018-ABS-0110 Efficacy and safety of SOFOSBUVIR/VELPATASVIR plus RIBAVIRIN for 12 or 24 weeks in genotype 1 or 2 HCV-INFECTED japanese patients with prior treatment failure to daa-based regimens (2018) (1)
- 1171 IDENTIFICATION OF GENETIC VARIANTS OF THE IL28B ASSOCIATED WITH SPONTANEOUS CLEARANCE OF HEPATITIS C VIRUS IN JAPANESE POPULATION (2010) (1)
- Prevalence of hepatitis C virus infection among liver diseases in Nanjing at China. (1992) (1)
- GB virus C/hepatitis G virus infection among Japanese patients with hematological diseases (1997) (1)
- High seropositivity for Entamoeba histolytica infection in Japanese homosexual men including male prostitutes (1992) (1)
- Evaluation of loss of heterozygosity before and after interferon therapy in patients with hepatitis C virus infection who developed hepatocellular carcinoma during follow up (2003) (1)
- Therapy of chronic hepatitis due to HCV. (1994) (1)
- Acute GB virus C/hepatitis G virus hepatitis preceding aplastic anemia (1997) (1)
- Vaccine temperature management in Lao People's Democratic Republic: A nationwide cross-sectional study (2021) (1)
- 1184 Inhibition of hepatitis B virus replication by small interfering RNAs (2003) (1)
- Pulsed field gel electrophoresis analysis conditions for molecular epidemiological group B streptococcus identification. (2008) (1)
- Multicenter observational study of reactivation of hepatitis B virus (HBV) caused by chemotherapy for solid tumors (ST). (2014) (1)
- Transition and problems of hepatitis B virus genotypes among patients with acute and chronic infection in Japan (2008) (1)
- [Hepatitis B virus genotype and the mutation related to clinical outcome]. (2015) (1)
- Perforated acute appendicitis in a patient with AIDS/HIV infection: Report of a case (2004) (1)
- [Prevention of viral hepatitis B in early infancy--hepatitis B vaccine (HBVac)]. (1984) (0)
- [Research achievements and questions on hepatitis B virus reactivation in hematological diseases]. (2019) (0)
- 910 GENOTYPING OF TA DINUCLEOTIDE REPEAT, rs72258881, COULD IMPROVE THE PREDICTION OF INTERFERON-BASED CHRONIC HEPATITIS C THERAPY AND SPONTANEOUS CLEARANCE FOLLOWING rs8099917 GENOTYPING (2013) (0)
- Diagnosis and Therapy for Attention-Getting Infections (2007) (0)
- [Clinical manifestations of hepatitis B virus genotypes]. (2004) (0)
- 1. Round-table discussion on usefulness and future perspectives of the genotype research (2005) (0)
- [Clinical and laboratory studies on cefoxitin in the field of digestive system (author's transl)]. (1980) (0)
- 651 MICA PLAYS AN OPPOSITE ROLE IN HEPATOCARCINOGENESIS BETWEEN HEPATITIS B AND HEPATITIS C (2013) (0)
- 590 Tracing the pandemic behavior of hepatitis C virus genotype 1B in Japan — association with the widespread injection treatment for schistosomiasis (2003) (0)
- [Mutation of HCV-RNA and determination of its genome by RT-PCR]. (2004) (0)
- The prevalence of 25(OH)D3 in the patients of South China with chronic HBV infection and high 25(OH)D3 related with low HBV DNA viral load (2014) (0)
- Correlation between hepatitis B virus core-related antigens and intrahepatic covalently closed circular DNA levels (2005) (0)
- Serum Levels of Wisteria Floribunda Agglutinin-Positive MAC-2 Binding Protein as Short-Term Predictors of Hepatocellular Carcinoma in Chronic Hepatitis B (2016) (0)
- [Diagnosis and therapy for attention-getting infections (discussion)]. (2007) (0)
- P760 HIGH-THROUGHPUT AND ULTRASENSITIVE NEXT-GENERATION PCR ASSAY FOR THE QUANTIFICATION OF THE HEPATITIS C VIRUS MUTATION AT CORE AMINO ACID 70 (2014) (0)
- [Practice of prophylaxis of B type hepatitis]. (1981) (0)
- Abstract 569: Comprehensive analyses of serum biomarkers associating with the increase of pro-angiogenic Tie2-expressing monocytes in patients with hepatocellular carcinoma (2015) (0)
- A large scale screening of HLA-class II-binding peptides from HBs and HBc peptide libraries (2016) (0)
- Measures to Prevent Transmission of MRSA to Patients with Bedsores during Mobile Bathing Service Visits (2007) (0)
- Hepatitis B infection among homosexual men in Japan. (1988) (0)
- Impact of Prophylactic Antiviral Therapy on Clinical Outcomes of Hepatitis B Virus Surface Antigen Positive Patients with Diffuse Large B-Cell Lymphoma Treated with Rituximab-Containing Chemotherapy (2018) (0)
- LBP18: HLA-PEPTIDE BINDING ANALYSIS BY THE CELL-SURFACE EXPRESSINO ASSAY (2015) (0)
- [Human Mac-2 binding protein glycosylation isomer (M2BPGi), a glycomarker, as a predictor of liver fibrosis for the patients with HCV]. (2015) (0)
- WS6-2LIVER DYSFUNCTION: CHEMOTHERAPY IN PATIENTS WITH CURRENT OR RESOLVED HEPATITIS B VIRAL INFECTION (2014) (0)
- A Case of Gastrointestinal Stromal Tumor with Internal Tandem Duplication in the 3′-Terminal of the KIT Juxtamembrane Domain (2005) (0)
- [Nucleic acid-based testing for hepatitis B viruss infectious disease]. (2005) (0)
- Association of HLA genes with hepatitis B infection in the Japanese population (2016) (0)
- [Evaluation of serum PIVKA-II by Lumipulse PrestoII assay]. (2009) (0)
- 129. The Effect of Pregnancy on HB Carrier (1985) (0)
- Genome-wide association study identified new susceptible genetic variants in HLA class I region for hepatitis B virus-related hepatocellular carcinoma (2018) (0)
- Serum Wisteria Floribunda agglutinin-positive sialylated mucin 1 as a biomarker of hepatic progenitor cell/biliary features in hepatocellular carcinoma and of recurrence after curative therapy (2017) (0)
- Suppression of HBV replication by the expression of nickase- and nuclease dead-Cas9 (2017) (0)
- GB virus C (GBV-C)/hepatitis G virus (HGV) infection in a hepatitis C virus hyper-endemic area in Japan (1997) (0)
- Description of a New Hepatitis B Virus C6 Subgenotype Found in the Papua Province of Indonesia and Suggested Renaming of a Tentative C6 Subgenotype Found in the Philippines as Subgenotype C7 (2009) (0)
- [Clinical use of antineoplastic cell antibody]. (1981) (0)
- Inter-spouse transmission of hepatitis C virus (2005) (0)
- Rapid publication Significance of antibody to the host cellular gene derived epitope GOR in chronic hepatitis C virus infection (1993) (0)
- [421] SUBGENOTYPES BA, C1 AND C2 OF HEPATITIS B VIRUS IN CHINA: CLINICAL AND VIROLOGICAL CHARACTERISTICS (2007) (0)
- Styrene Maleic Acid Neocarzinostain-Transcatheter Arterial Embolization for Hepatocellular Carcinoma (1998) (0)
- [Direct cytopathic effects of particular hepatitis B virus genotypes in immunosuppressive condition]. (2010) (0)
- Treatment Effects and Resistance-Associated Variants of Sofosbuvir Regimen for Japanese Patients with Chronic Hepatitis C Virus Genotypes 1 and 2 (2017) (0)
- Exploring the genetic diversity of the Japanese Population: Insights from a Large-Scale Whole Genome Sequencing Analysis (2023) (0)
- [Molecular evolutionary classification of hepatitis B virus]. (1995) (0)
- Cost-effectiveness analysis for preventing hepatitis B virus reactivation-related death in Japan (2020) (0)
- Retreatment with Interferon in Patients with Chronic Hepatitis C Who Failed with the Initial Course of Interferon Therapy (1995) (0)
- Case of acute hepatitis C contracted by contact with blood while administering first aid to a spouse with type C cirrhosis (2015) (0)
- 1128 PREDICTION MODEL OF ANEMIA USING ITPA GENOTYPE IDENTIFIES PATIENTS AT HIGH RISK OF ANEMIA AND TREATMENT FAILURE WITH PEGYLATED-INTERFERON PLUS RIBAVIRIN FOR CHRONIC HEPATITIS C (2012) (0)
- Independent evolution of multi-dominant viral genome species observed in a hepatitis C virus carrier (2022) (0)
- [Molecular evolutionary analyses of organisms]. (1995) (0)
- 1177 Predicting relapse after cessation of lamivudine monotherapy for chronic hepatitis B virus infection-application of newly developed HBV real-time detection direct test (2003) (0)
- usefulness of mac-2 binding protein glycosylation isomer (m2bpgi) for advanced fibrosis and hepatocellular carcinoma in patients with non-alcoholic fatty liver disease : 2193 (2015) (0)
- A process for the clinical examination due to the structure of the bound immunoglobulin G oligosaccharides (1995) (0)
- [Genome-wide association study and clinical application]. (2011) (0)
- Serum Levels of M2BPGi as Short-Term Predictors of Hepatocellular Carcinoma in Untreated Chronic Hepatitis B Patients (2017) (0)
- F11-5 Serum hepatitis C virus core protein level as predictor of response to interferon-ALFA therapy (1995) (0)
- Subtypes of hepatitis B virus genotype C in China: distribution and characteristics including two new subgenotypes. (2006) (0)
- [Preemptive therapy for HBV reactivation by serial HBV-DNA monitoring]. (2010) (0)
- Subject Index Vol. 44, 2001 (2002) (0)
- A Study of Infection Control and Prevention Related to Cleaning and Disinfection of Nasopharyngeal Endoscopes (2006) (0)
- CLINICAL — LIVER Consumption of n-3 Fatty Acids and Fish Reduces Risk of Hepatocellular Carcinoma (2012) (0)
- Abstract — 31st Annual Meeting of the Japan Society of HepatologyP-32 Quantitation of serum HCV core protein level in patients with various HCV genotypes (1995) (0)
- [The origin and evolution of hepatitis C virus]. (2011) (0)
- 563 New combination test for hepatitis C virus genotype and amplicor GT HCV monitor test V 2.0 (2003) (0)
- Cerebral Syphilitic Gumma Suspected to have Developed during Primary Syphilis and Treated with Antibiotics in an HIV-Negative Patient (2018) (0)
- [Molecular evolutionary analysis of hepatitis C virus--detection of positive selective sites]. (2004) (0)
- Scirrhous colonic metastasis from lobular carcinoma of breast (2013) (0)
- P757 REDUCING POLYMORPHISMS CONSISTING OF (TA)N DINUCLEOTIDE REPEAT NEAR IL28B GENE ASSOCIATE WITH THE DEVIATION OF IL28B SNPS AND AFFECT VIRAL RESPONSE OF PEGIFN/RBV (2014) (0)
- PL-1 Clinical significance of quantitation of hepatitis C virus (HCV) core antigen in serum (1995) (0)
- Mutation patterns for two flaviviruses: hepatitis C virus and GB virus C/hepatitis G virus (1999) (0)
- [HBV--clinical impact of HBV genotypes]. (2003) (0)
- Genotyping of Hepatitic B virus-Genotype A to G by Multiplex-PCR (2007) (0)
- Trends of hepatitis B virus genotype distribution in chronic hepatitis B patients in Japan (2022) (0)
- PREDICTION OF RESPONSE TO PEGYLATED-INTERFERON FOR CHRONIC HEPATITIS C: IMPACT OF SNPS NEAR THE IL28B GENE AND MUTATIONS IN THE ISDR OF HCV REVEALED BY DATA MINING ANALYSIS (2010) (0)
- Abstract 3354: Cancer-associated or cirrhosis fibroblasts recovered from hepatocellular carcinoma promote macrophages and cancer cells to progressive phenotype (2015) (0)
- Abstracts of selected papers presented at the 29th annual meeting of the Japanese society of gastroenterology Kofu, Japan, November 5–7, 1987 (1988) (0)
- Host Genetics and Responses to Antiviral Therapy in Chronic Hepatitis C (2016) (0)
- Sensitive Detection of Minor Variants and Viral Haplotypes Using Single-Molecule, Real Time SMRT ® sequencing (2012) (0)
- An Investigation of the Patient's Home Environment Tried to Find the Cause of Humidifier Lung (2005) (0)
- [Hepatitis C virus infection as sexually transmitted diseases]. (1995) (0)
- Epidemiological and clinical diffeences between hepatitis B virus genotype B with and without recombination with genotype C (2003) (0)
- 421.The Effect of Pregnancy on HB Carrier : XXXXXXXII Infectious Disease(II) (1983) (0)
- P167: CD34 expression can predict a higher risk of development of Hepatocellular carcinoma in the setting of chronic Hepatitis C‐related cirrhosis (2015) (0)
- Humoral immunoreactivity to HCV core antigen in patients with chronic hepatitis C. (1997) (0)
- Subject Index Vol. 46, 2003 (2003) (0)
- 469 ITPA GENE VARIANT PROTECTS AGAINST TREATMENT-INDUCED ANEMIA AND IMPROVES VIRAL CLEARANCE BY PEGYLATED INTERFERON-ALFA AND RIBAVIRIN THERAPY IN CHRONIC HEPATITIS C PATIENTS (2011) (0)
- Hepatitis G virus (HGC) infection and subtypes of GB virus C/HCV positive liver transplant recipients (1998) (0)
- Regulation of MEK inhibitor selumetinib sensitivity by AKT phosphorylation in the novel BRAF L525R mutant (2023) (0)
- The interaction of a single‐nucleotide polymorphism with age on response to interferon‐α and ribavirin therapy in female patients with hepatitis C infection (2014) (0)
- GB virus C/hepatitis G virus infection in patients with chronic hepatitis C virus infection (1998) (0)
- Elevated serum wisteria floribunda agglutinin-positive mac-2-binding protein levels associated with risks of diabetes and endstage renal diseases among patients with hepatitis C virus infection (2017) (0)
- Molecular Evolutionary Classification of Hepatitis C Viruses and their Divergence Times (1994) (0)
- Familial clustering of GB virus C/hepatitis G virus infection among the Jewish population in Uzbekistan (1997) (0)
- Detection of Hepatitis C Virus Core Antibody and Hepatitis C Virus RNA by Polymerase Chain Reaction in Non-A Non-B Liver Disease : Its Correlation with C100-3 Antibody (1993) (0)
- Existence of poly HSA binding activity in Region S. (1987) (0)
- [Genome-wide association study on and the clinical application to chronic hepatitis C]. (2011) (0)
- Serum hepatitis C virus core protein level during interferon-α therapy in patients with chronic hepatitis C: relationship between biochemical and virologic responses (1997) (0)
- Enterococcus casseliflavus KB1733 Isolated from a Traditional Japanese Pickle Induces Interferon-Lambda Production in Human Intestinal Epithelial Cells (2022) (0)
- Correction to: APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy (2022) (0)
- Functional association of cellular microtubules with viral capsid assembly supports efficient hepatitis B virus replication (2017) (0)
- P.030 C1858 was specific in HBV genotype C in patients from northern Vietnam but not in Japanese patients (2006) (0)
- Profiles of HBV DNA, ALT, and HBeAg status after stopping lamivudine in patients with HBeAg seroconversion (2007) (0)
- Possible biological mechanisms of entecavir vs. tenofovir disoproxil fumarate on reducing the risk of HCC. (2023) (0)
- NOTES Nonhepatic Cell Lines HeLa and 293 Support Efficient Replication of the Hepatitis C Virus Genotype 2a Subgenomic Replicon (2004) (0)
- P711 A NOVEL GENETIC MAKER TO IMPROVE THE PREDICTION OF HCV SPONTANEOUS CLEARANCE: POLYMORPHISMS CONSISTING OF (TA)N DINUCLEOTIDE REPEAT NEAR IL28B GENE (2014) (0)
- Simulationand Molecular Docking as Determined by Long-Term Clinical Hepatitis B Virus with Viral Breakthrough Mechanism of Entecavir Resistance of (2013) (0)
- P061 Association of HLA class II genes with response to hepatitis B vaccine in Japanese (2017) (0)
- Three-year assessment of entecavir resistance in chronic hepatitis B patients and the mechanism of viral breakthrough by the resistance substitutions (2008) (0)
- P166: A study of the prevalence and effects of insulin resistance in chronic hepatitis C patients with genotype 4 (2015) (0)
- Differences of Clinical Characteristics Among Japanese Patients with Hepatitis B Virus Genotypes B and C (2004) (0)
- Genotyping Hepatitis Virus: New Developments and Clinical Impact: 1st MMRF Meeting on Viral Hepatitis in Asia, Tokyo, January 2003: Proceedings (2003) (0)
- Association of HLA-DPB1 alleles with chronic hepatitis B infection in the Japanese population (2015) (0)
- [Molecular evolution of hepatitis viruses]. (1999) (0)
- Interferon-α Therapy Exerts Selective Pressure on Hepatitis C Virus Quasispecies Equilibrium (1999) (0)
- A Study of Washing and Disinfecting for Humidifier at Home to Prevent Humidifier Lung (2006) (0)
- Genome-Wide Association Study for Chronic Hepatitis B Infection in the Thai Population (2022) (0)
- Contents Vol. 46, 2003 (2003) (0)
- P-34 Comparison of HCV-RNA concentrations and variations of E2/NS1 regions between before and after aids occurence in a patient with hemophilia A and hepatitis C (1995) (0)
- JSH Consensus Kobe 2009: Diagnosis and Treatment of Hepatitis B (2009) (0)
- Mutation Pattern of Hepatitis C Virus and Its Application to Therapy (1999) (0)
- [The positive rate of hepatitis C virus antibody detected by the second generation method in pregnant women and influence of pregnancy and delivery on HCV infection]. (1992) (0)
- 421 OCCULT HEPATITIS B VIRUS INFECTION AMONG HEPATOCELLULAR CARCINOMA PATIENTS IN JAPAN (2013) (0)
- P0786 : 100% SVR12 with ledipasvir/sofosbuvir±ribavirin for 12 weeks in Japanese patients with chronic genotype 1 hepatitis C virus who previously failed therapy with protease inhibitor + pegylated interferonα + ribavirin (2015) (0)
- Serum Wisteria Floribunda Agglutinin-Positive Sialylated Mucin 1 as a Marker of Progenitor/Biliary Features in Hepatocellular Carcinoma (2017) (0)
- 642 Outbreak of hepatitis C virus infection through contaminated fibrinogen concentrates in Japan-tracing the source by molecular evolutionary analysis (2003) (0)
- [Laboratory and clinical studies of cefotiam in digestive diseases]. (1984) (0)
- [Predicting sustained virological response in chronic hepatitis C patients treated with pegylated interferon and ribavirin using a novel highly sensitive Real-time detection PCR assay]. (2007) (0)
- 371. The Effect of Pregnancy on HB Carrier (1984) (0)
- Smoking is a risk factor for development of adult T-cell leukemia/lymphoma in Japanese human T-cell leukemia virus type-1 carriers (2016) (0)
- P28: In vitro replication competence of a hepatitis B genotype D/A recombinant virus: dissimilar biological behaviour regarding its parental genotypes (2013) (0)
- P758 ASSOCIATION OF LIVER DISEASES-RELATED SINGLE NUCLEOTIDE POLYMORPHISMS ON DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN JAPANESE PATIENTS WITH HEPATITIS C VIRUS (2014) (0)
- A case of chronic HCV-positive hepatitis who was thought to suppress HCC recurrence after treated with percutaneous radiofrequency ablation against post-operative HCC recurrence, followed by interferon therapy, resulting in sustained-complete response (2004) (0)
- Hepatitis B virus and its genotypes: new development in Japan. (2010) (0)
- [Molecular evolutionary analysis of hepatitis B virus (HBV) and genetic classification]. (1993) (0)
- Erratum to: A thymine–adenine dinucleotide repeat polymorphism near IL28B is associated with spontaneous clearance of hepatitis C virus (2016) (0)
- Erratum to: Virological and Clinical Characteristics of Hepatitis B Virus Genotype A (2017) (0)
- [Severe and fatal non-A non-B hepatitis in 4 young and children]. (1984) (0)
- Antibody to the host cellular gene-derived epitope GOR-1 in liver transplant recipients with hepatitis C virus infection. (1997) (0)
- Novel Cell Culture-Adapted Genotype 2 a Hepatitis C Virus Infectious (2012) (0)
- [A case of hepatoma with a remarkable response to gamma-interferon administration]. (1986) (0)
- [Hepatitis C virus infection as a sexually transmitted disease]. (2004) (0)
- Prediction Model with HLA-A*33:03 Reveals Number of Days to Develop Liver Cancer from Blood Test (2023) (0)
- Title: Novel Cell Culture-Adapted Genotype 2a Hepatitis C Virus Infectious Clone 1 2 (2012) (0)
- What's Hot in the Red Journal This Month? (2009) (0)
- [485] ROLE OF HBV GENOTYPES, CORE PROMOTER/PRECORE MUTATIONS AND HBVDNA LEVELS ON HEPATOCARCINOGENESIS (2007) (0)
- [Molecular evolutionary analysis of GB viruses and hepatitis G virus]. (1997) (0)
- A patient with chronic active hepatitis B who lost serum HBsAg spontaneously accompanied by histological healing. (1993) (0)
- [Molecular evolutionary analysis of hepatitis C virus--phylogenetic tree and divergence time]. (1995) (0)
- Serum HBcrAg and hepatocellular carcinoma in a Taiwanese population seronegative for HBsAg and anti-HCV. (2022) (0)
- 49 HEPATITIS B VIRUS X PROTEIN INDUCED MODULATION IN THE EXPRESSION OF MIR-222 IN MALIGNANT HEPATOCYTES IN VITRO (2012) (0)
- Host Genetic Factors Control Hepatitis C Virus Infection (2012) (0)
- 1071. Retrospective study evaluating the cytokine dynamics in COVID-19 patients who were treated with casirivimab/imdevimab (2022) (0)
- 3. Hepatitis C virus (2005) (0)
- Tu1016 Safety and Efficacy of Ledipasvir/Sofosbuvir for the Treatment of Genotype 1 Hepatitis C in Patients Aged 65 Years or Older: A Retrospective Analysis of Phase 3 (2015) (0)
- B型肝炎ウイルス(HBV)とヒト免疫不全ウイルス(HIV‐1)に重複感染した同性愛パートナーからキスによりHBVのみが感染したと考えられる1症例 (2003) (0)
- Spontaneous Cure of Chronic Hepatitis B with Hapatocellular Carcinoma and Concomitant HBsAg Reappearance and Disappearance (1997) (0)
- MGeND: an integrated database for Japanese clinical and genomic information (2019) (0)
- Hepatitis B Virus Genotype and Mutations Related to Clinical Outcome (2018) (0)
- Utility of Mac-2 Binding Protein Glycosylation Isomer (M2BPGi) for Advanced Fibrosis and Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease (2016) (0)
- Molecular epidemiology of hepatitis C infection among intravenous drug users in Guangxi Province, Southern China (1995) (0)
- Activated Fibroblasts Recovered from the Cirrhotic Liver Provide Malignancy-Prone Phenotypes to Cancer Cells and Macrophages: Comparable Capacity with Cancer-Associated Fibroblasts in Hepatocellular Carcinoma (2016) (0)
- Special Lecture (2010) (0)
- Contents Vol. 44, 2001 (2002) (0)
- Method clinical examination based on the structures of oligosaccharides bound to immunoglobin g. (1995) (0)
- Genome-wide copy number variation analysis of hepatitis B infection in a Japanese population (2021) (0)
- Chronic Hepatitis C Patients Pegylated Interferon and Ribavirin in Sustained Virological Response to TaqMan HCV Assays for Prediction of and Roche Cobas AmpliPrep / Cobas Abbott RealTime Hepatitis C Virus ( HCV ) (2009) (0)
- [Significance of serological genotyping of hepatitis C virus in Japanese patients with chronic liver disease due to hepatitis C]. (1994) (0)
- 517 Detection of hepatitis B virus core-related antigens as a marker for the monitoring of viral activity during nucleoside analogue therapy (2006) (0)
- [Molecular genotypes of hepatitis C virus and their divergence times]. (1993) (0)
- [Analysis of intrafamilial and spouse to spouse transmission of hepatitis C virus by molecular evolutionary method]. (1995) (0)
- 441 THE ITPA GENOTYPE CORRELATES WITH HEMOLYTIC ANEMIA AND OUTCOME AFTER TREATMENT WITH PEGYLATED-INTERFERON AND RIBAVIRIN IN GENOTYPE IB CHRONIC HEPATITIS C (2011) (0)
- Full‐genome analysis of hepatitis C virus in HIV‐coinfected hemophiliac Japanese patients (2020) (0)
- [Hepatitis B virus genotypes and mutations in asymptomatic carriers]. (2004) (0)
- Contents Vol. 49, 2006 (2006) (0)
- Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (2021) (0)
- Toll-Like Receptor 4 Pathway Mediate Liver Fibrosis in Chimeric Mice with Human Hepatocytes Persistently Infected with HBV (2016) (0)
- [Hepatitis B virus genotype and the mutation related to clinical outcome]. (2011) (0)
- Subject Index Vol. 49, 2006 (2006) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Masashi Mizokami?
Masashi Mizokami is affiliated with the following schools:
